header logo image


Page 533«..1020..532533534535..540550..»

Drug factories: GMOs and gene editing are poised to transform medicine. Here’s how. – Genetic Literacy Project

May 27th, 2020 12:09 pm

No one likes getting a shot at the doctors office. As kids, we werent used to having a sharp needle prick our skin, let alone by someone doing it on purpose. An estimated 10% of the population is affected by trypanophobia the fear of needles or injections. Luckily, for most, shots are an infrequent occurrence often limited to vaccinations. However, for millions of others, injections are a more frequent fact of life required in dealing with disease. The need for these injections and their associated doctor visits mean the physical discomfort of the treatment is often compounded by a financial burden.

Fortunately, plant biotechnology is poised to drastically improve how we consume medication. Using the modern tools of genetic engineering, researchers are developing plant-based drugs that are cheaper, easier to take and even more effective than their existing counterparts.

Cant more medicines be reformulated for oral delivery?

While many diseases can be treated with orally administered medications, other drugs such as biologics or biopharmaceuticals, medicines derived from living organisms, must be delivered using other strategies. Conventional drugs like aspirin are chemically synthesized and can survive digestion, whereas biologics like hormones, antibodies, enzymes, and other complex organic molecules are vulnerable to degradation by enzymes in our saliva and stomach, as well as environmental conditions like pH and heat. This makes biologics in pill form unlikely to survive the harsh environment of the digestive tract.

Pricey biologics

In addition to the unpleasant nature of biologic injections is their associated costs. Biologics are made by taking the DNA blueprint for the molecule and expressing it in bacterial, yeast, or mammalian cells. Once these cells, typically grown in large vats filled with nutrient media, produce the molecule of interest, it must be isolated and purified. Each step of this process must be exact and carefully maintained as small variations may change the structure and identity of the drug, potentially altering its behavior. This complex manufacturing process in addition to more rigorous FDA regulations mean higher drug prices for consumers. Combined with the price of doctor visits to get these frequent injections or infusions, the annual cost of some biologics can reach hundreds of thousands of dollars.

There are more than 200 FDA-approved biologic drugs. While less than two percent of people in the US rely on biologics, they make up 40 percent of prescription drug spending. Identifying a better way to produce and administer biologics has the potential to ease the physical and financial burden associated with these drugs. For this reason, researchers are turning to the original inspiration for medications: plants.

Turning plants into pharmaceutical factories

Evidence for plant use in medicine dates back all the way to the Palaeolithic Age. But instead of trying to find new plants that produce medically relevant compounds, researchers are turning to genetic engineering to express the same biologics currently grown in bacterial, yeast, or mammalian cells.

Producing biologics in plants has a number of advantages. Plants are potentially less costly to grow, requiring inexpensive fertilizers instead of specialized cell culture growth media. Plants can also be grown in fields or greenhouses without requiring sterile environments, meaning that scaling up production would just require more growing area as opposed to additional expensive bioreactors. An added benefit is that plants do not serve as hosts for human pathogens, reducing the likelihood of harm from contaminants that bacterial or mammalian cells may house.

Once the drug-producing plants are grown, the medically relevant proteins may be extracted and purified. But plants allow for this platform to be taken one step further: by turning the biologic- expressing plants into a freeze-dried (lyophilized) powder and placing it into a capsule, the drugs can be delivered orally. Plant cell walls contain cellulose which cannot be digested by enzymes in the stomach but can be broken down by the commensal bacteria living in our intestines. Plant-encapsulated drugs are then released in the blood-rich absorptive environment of the small intestine, where they become bioavailable and distributed to target tissues. By producing these drugs in a lyophilized form, manufacturers can cut out the expensive purification process and the need for cold transport and storage.

Current research efforts

Theres been some reported success using this method, including a March 2020 paper from a team at the University of Pennsylvania describing a lettuce expressing a novel human insulin-like growth factor-1 (IGF-1). IGF-1 helps promote skeletal muscle and bone development. For this reason, IGF-1 injections have been used in the treatment of several muscle disorders and have the potential for therapeutic benefit in healing bone fractures.

To study if plant-grown IGF-1 might be an effective replacement for traditional IGF injections, the team modified human IGF-1 to allow for uptake through the gut. They found that their modified version not only stimulated proliferation of several cell types better than current commercial IGF-1, but also that the plant-encapsulated drug could be administered orally to mice and would effectively be delivered to blood serum. The team also found that this administration of the drug significantly increased bone density in diabetic mice as compared to a control group.

In addition to medication production, companies are also looking to utilize some of the benefits of plant-based production for vaccines. Medicago, a Canada-based company seeking approval for their plant-produced flu vaccine, has announced that using this same technology, they have produced a candidate vaccine for COVID-19 in twenty days. By growing the protein for the vaccine in plants, as opposed to using eggs to propagate the virus, Medicago has been able to cut the cost and time required to produce a new vaccine. The vaccine is now awaiting clinical testing and FDA approval.

Similar to the work on orally administered IGF-1, theres also a lot of interest in making edible vaccines. In the future, you may no longer need to go to a clinic to get a seasonal flu vaccine, but instead eat a salad made with vaccine-containing lettuce or tomatoes. This could potentially reduce patient discomfort and increase vaccine compliance, minimizing everybodys risk of contracting infectious diseases. Edible vaccines would also help expand access to immunization in parts of the world were delivering vaccines may be difficult.

Plant-produced pharmaceuticals have the potential to improve the quality of life for millions of people by reducing the physical and financial burden of relying on biologics to stay healthy. There may even come a day when getting a shot at the doctors office is a thing of the past replaced by a quick trip to the grocery store.

Tautvydas Shuipys is a PhD candidate in the Genetics and Genomics Graduate Program at the University of Florida. Follow him on Twitter @tshuipys

Go here to see the original:
Drug factories: GMOs and gene editing are poised to transform medicine. Here's how. - Genetic Literacy Project

Read More...

Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market : Industry Analysis and… – Azizsalon News

May 27th, 2020 12:09 pm

Global Clustered Regularly Interspaced Short Palindromic Repeats Market was valued US$ 711.24 Mn in 2018 and is expected to reach US$ XX Mn by 2026, at a CAGR of XX% during a forecast period.

REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/21900/

The key driving factors of the global clustered regularly interspaced short palindromic repeats market are increasing demand for drug discovery, a risk of congenital anomalies, late pregnancies leading to birth disorders, increasing size of the geriatric population, and investment in path-breaking research technology. Lack of awareness and probable misappropriated use of the CRISPR gene editing tool are the major factors limiting the CRISPR market growth.

The global clustered regularly interspaced short palindromic repeats market is segmented into the products, application, end-uses, and region. In terms of products, the global clustered regularly interspaced short palindromic repeats market is classified into design tools, plasmids, vectors, library, control kits, proteins, genomic RNA, and other products.

Based on the application, the global clustered regularly interspaced short palindromic repeats market is divided into genome editing & genetic engineering, GRNA database & gene library, CRISPR plasmid, human stem cells, and cell line engineering. By application, genome editing & genetic engineering is used for modifying an organisms genome, where deletions, insertions or replacements are carried out in the DNA of the living organism by making use of molecular machinery and engineered nucleases.

In terms of end-uses, global clustered regularly interspaced short palindromic repeats market is segmented into industrial biotech biological research, agricultural research, and therapeutics and drug discovery. changing lifestyles, late pregnancies leading to birth disorders, increasing demand for drug discovery, synthetic genes leading the way, investment in path-breaking research technology and aging genetic disorders are drive the growth of biological research segment.

Based on regions, the global clustered regularly interspaced short palindromic repeats market is divided into five main regions are America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Geographically, Asia-Pacific market is anticipated to be the fastest-growing region in the global CRISPR market due to the large population of Japan and China is suffering from diabetes and other peripheral diseases, and the prevalence of these diseases growing at a very reckless rate.

Key players operating in global clustered regularly interspaced short palindromic repeats market are Addgene, CRISPR Therapeutics, Editas Medicine, Egenesis, Inc., GE Healthcare, GenScript Biotech Corporation, Horizon Discovery Group PLC, Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., and Lonza Group.

DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/21900/

The objective of the report is to present comprehensive analysis of Global Clustered Regularly Interspaced Short Palindromic Repeats Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Clustered Regularly Interspaced Short Palindromic Repeats Market dynamics, structure by analyzing the market segments, and project the Global Clustered Regularly Interspaced Short Palindromic Repeats Market size. Clear representation of competitive analysis of key players by Global Clustered Regularly Interspaced Short Palindromic Repeats Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Clustered Regularly Interspaced Short Palindromic Repeats Market make the report investors guide.The Scope of the Global Clustered Regularly Interspaced Short Palindromic Repeats Market:

Global clustered regularly interspaced short palindromic repeats market, by products:

Design tools Plasmids Vectors Library Control kits Proteins Genomic RNA Other productsGlobal Clustered Regularly Interspaced Short Palindromic Repeats Market, By Application:

Genome editing & genetic engineering GRNA database & gene library CRISPR plasmid Human stem cells Cell line engineeringGlobal Clustered Regularly Interspaced Short Palindromic Repeats Market, By End-Uses:

Industrial biotech Biological research Agricultural research Therapeutics and drug discoveryGlobal Clustered Regularly Interspaced Short Palindromic Repeats Market, By Region:

North America Europe Middle East & Africa Asia Pacific Latin AmericaKey Players Operating In Global Clustered Regularly Interspaced Short Palindromic Repeats Market:

Addgene CRISPR Therapeutics Editas Medicine Egenesis, Inc. GE Healthcare GenScript Biotech Corporation Horizon Discovery Group PLC Integrated DNA Technologies, Inc. Intellia Therapeutics, Inc. Lonza Group

MAJOR TOC OF THE REPORT

Chapter One: Clustered Regularly Interspaced Short Palindromic Repeat Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Clustered Regularly Interspaced Short Palindromic Repeat Market Competition, by Players

Chapter Four: Global Clustered Regularly Interspaced Short Palindromic Repeat Market Size by Regions

Chapter Five: North America Clustered Regularly Interspaced Short Palindromic Repeat Revenue by Countries

Chapter Six: Europe Clustered Regularly Interspaced Short Palindromic Repeat Revenue by Countries

Chapter Seven: Asia-Pacific Clustered Regularly Interspaced Short Palindromic Repeat Revenue by Countries

Chapter Eight: South America Clustered Regularly Interspaced Short Palindromic Repeat Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Clustered Regularly Interspaced Short Palindromic Repeat by Countries

Chapter Ten: Global Clustered Regularly Interspaced Short Palindromic Repeat Market Segment by Type

Chapter Eleven: Global Clustered Regularly Interspaced Short Palindromic Repeat Market Segment by Application

Chapter Twelve: Global Clustered Regularly Interspaced Short Palindromic Repeat Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Clustered Regularly Interspaced Short Palindromic Repeat Market Report at: https://www.maximizemarketresearch.com/market-report/global-clustered-regularly-interspaced-short-palindromic-repeats-market/21900/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

Connect With us at LinkedIn LinkedIn

Connect with us at Facebook Facebook

Contact With Us at Twitter Twitter

Originally posted here:
Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market : Industry Analysis and... - Azizsalon News

Read More...

Global Food Enzymes Market (2020 to 2025) – Recent Innovations in the Market – GlobeNewswire

May 27th, 2020 12:09 pm

Dublin, May 26, 2020 (GLOBE NEWSWIRE) -- The "Food Enzymes Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The food enzymes market is bifurcated by type into variants such as carbohydrates, lipases, and proteases. Innovation has enabled the players to exploit several end-user industries such as bakery, dairy, beverages, meat products, and confectionery, consequently triggering the opportunities in the food enzymes market to be progressing at a compound annual growth rate (CAGR) of 5.90% during the forecast period 2019-2025.

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the food enzyme market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis.

The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various types of application industry in global food enzyme market, and their specific advantages.

The booming trend of fast-food in North America has augmented the trade of cheese, indirectly impacting the market of protease food enzyme. According to the Centers for Disease Control and Prevention, in 2016, one out of three Americans (36%) consumed a meal at fast-food eateries on any given day. Some of the leading fast-food chains across the U.S are McDonald's, KFC, Pizza Hut, Domino's Pizza and Burger Kings. Application of cheese in these F&B giants can be indicated by the fact that Leprino Foods, a leading market player, often rated as America's all-time monopolist, manages to converge an annual revenue of $3 billion by supplying mozzarella cheese to Pizza Hut, Domino's, and Papa John's

Similarly, McDonald's for their buns claims to apply enzymes such as amylases. And KFC, the world's most popular chicken restaurant chain is now operating in 135 countries with more than 22,000 restaurants globally. Hence, the trend of processed food supplemented by retail outlets in North America is projecting the food enzyme market towards exponential growth.

Food Enzymes Market Trends and Growth Drivers:

Some of the key players operating in the global food enzyme market are Royal DSM N.V, EI DuPont DE Nemours & Co., Novozymes A/S, Chr Hansen A/S, Biocatalyst limited, AB enzymes GMBH, Kerry group PLCAum Enzymes, Amano Enzyme Inc., and Enmex SA DE CV.

Key Questions Addressed in the Food Enzyme Market Report

A few focus points of this Research are given below:

Key Topics Covered:

1. Food Enzymes Market - Overview1.1. Definitions and Scope

2. Food Enzymes Market - Executive summary2.1. Market Revenue, Market Size and Key Trends by Company2.2. Key Trends by type of Application2.3. Key Trends segmented by Geography

3. Food Enzymes Market 3.1. Comparative analysis3.1.1. Product Benchmarking - Top 10 companies3.1.2. Top 5 Financials Analysis3.1.3. Market Value split by Top 10 companies3.1.4. Patent Analysis - Top 10 companies3.1.5. Pricing Analysis

4. Food Enzymes Market Forces4.1. Drivers4.2. Constraints4.3. Challenges4.4. Porters five force model4.4.1. Bargaining power of suppliers4.4.2. Bargaining powers of customers4.4.3. Threat of new entrants4.4.4. Rivalry among existing players4.4.5. Threat of substitutes

5. Food Enzymes Market -Strategic analysis5.1. Value chain analysis5.2. Opportunities analysis5.3. Product life cycle5.4. Suppliers and distributors Market Share

6. Food Enzymes Market - By Type (Market Size -$Million / $Billion)6.1. Market Size and Market Share Analysis 6.2. Application Revenue and Trend Research6.3. Product Segment Analysis6.3.1. Introduction6.3.2. Amylases6.3.3. Catalases6.3.4. Lactases6.3.5. Proteases6.3.6. Lipases6.3.7. Rennet6.3.8. Cellulase6.3.9. Others (Actinidin, Bromelain, Ficin, Lypoxygenase, Invertase, Raffinase & Others)

7. Food Enzymes Market - By Source (Market Size -$Million / $Billion)7.1. Introduction 7.2. Plant-Based Enzymes7.3. Animal-Based Enzymes7.4. Microorganism-Based Enzymes7.4.1. Bacterial7.4.2. Fungal7.4.3. Yeast

8. Food Enzymes Market - By Application (Market Size -$Million / $Billion)8.1. Introduction 8.1.1. Bakery8.1.1.1. Bread8.1.1.2. Cakes8.1.1.3. Crackers & Cookies8.1.2. Dairy 8.1.3. Beverages8.1.4. Meat Products8.1.5. Confectionery8.1.6. Fruits & Vegetables Processing8.1.7. Oil & Fats8.1.8. Starch Processing8.1.9. Inulin & Others

9. Food Enzymes - By Geography (Market Size -$Million / $Billion)9.1. Food Enzymes Market - North America Segment Research9.2. North America Market Research (Million / $Billion)9.2.1. Segment type Size and Market Size Analysis 9.2.2. Revenue and Trends9.2.3. Application Revenue and Trends by type of Application9.2.4. Company Revenue and Product Analysis9.2.5. North America Product type and Application Market Size9.2.5.1. U.S.9.2.5.2. Canada 9.2.5.3. Mexico 9.2.5.4. Rest of North America9.3. Food Enzymes - South America Segment Research9.4. South America Market Research (Market Size -$Million / $Billion)9.4.1. Segment type Size and Market Size Analysis 9.4.2. Revenue and Trends9.4.3. Application Revenue and Trends by type of Application9.4.4. Company Revenue and Product Analysis9.4.5. South America Product type and Application Market Size9.4.5.1. Brazil 9.4.5.2. Venezuela9.4.5.3. Argentina9.4.5.4. Ecuador9.4.5.5. Peru9.4.5.6. Colombia 9.4.5.7. Costa Rica9.4.5.8. Rest of South America9.5. Food Enzymes - Europe Segment Research9.6. Europe Market Research (Market Size -$Million / $Billion)9.6.1. Segment type Size and Market Size Analysis 9.6.2. Revenue and Trends9.6.3. Application Revenue and Trends by type of Application9.6.4. Company Revenue and Product Analysis9.6.5. Europe Segment Product type and Application Market Size9.6.5.1. U.K 9.6.5.2. Germany 9.6.5.3. Italy 9.6.5.4. France9.6.5.5. Netherlands9.6.5.6. Belgium9.6.5.7. Spain9.6.5.8. Denmark9.6.5.9. Rest of Europe9.7. Food Enzymes - APAC Segment Research9.8. APAC Market Research (Market Size -$Million / $Billion)9.8.1. Segment type Size and Market Size Analysis 9.8.2. Revenue and Trends9.8.3. Application Revenue and Trends by type of Application9.8.4. Company Revenue and Product Analysis9.8.5. APAC Segment - Product type and Application Market Size9.8.5.1. China 9.8.5.2. Australia9.8.5.3. Japan 9.8.5.4. South Korea9.8.5.5. India9.8.5.6. Taiwan9.8.5.7. Malaysia

10. Food Enzymes Market - Entropy10.1. New product launches10.2. M&A's, collaborations, JVs and partnerships

11. Food Enzymes Market Company Analysis11.1. Market Share, Company Revenue, Products, M&A, Developments11.2. Royal DSM N.V11.3. EI DuPont DE Nemours & Co11.4. Novozymes A/S11.5. Biocatalyst limited11.6. AB enzymes GMBH11.7. Kerry group PLC

12. Food Enzymes Market -Appendix12.1. Abbreviations12.2. Sources

For more information about this report visit https://www.researchandmarkets.com/r/ujmz9s

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

The rest is here:
Global Food Enzymes Market (2020 to 2025) - Recent Innovations in the Market - GlobeNewswire

Read More...

Global Genome Editing/Genome Engineering Market 2020 by Company, Regions, Type and Application, Forecast to 2026 – 3rd Watch News

May 27th, 2020 12:09 pm

The dedicated research report titled Global Genome Editing/Genome Engineering Market 2020 by Company, Regions, Type and Application, Forecast to 2026 envelopes all-in information of the market and vital understanding on the global market at a holistic global perspective, rendering statistical analysis, and perspective of integral growth enablers prompting favorable growth across regions. The report is the result of an in-depth analysis of the latest developments which focus on the growth opportunities, the basic criteria, challenges dominant in the global Genome Editing/Genome Engineering market, and their consequential effects on the target market. The report analyzes various products or service implementations in various end-user industries and analyses technology used to create and operate these products/ services in the global market.

Key Vendor/Manufacturers In The Market:

The study analysis examines each market player according to its market share, production footprint, and growth rate during 2020 to 2026 time-frame. Then, the market study determines the recent launches, agreements, R&D projects, and business strategies of the market players. Great insights such as Genome Editing/Genome Engineering market revenue and market share of the global market are also covered. Additionally company basic information, manufacturing base, and competitors list is being provided for each listed manufacturers: Thermo Fisher Scientific, Merck KGaA, Horizon Discovery, Genscript USA, Sangamo Biosciences, Integrated DNA Technologies, Origene Technologies, Transposagen Biopharmaceuticals, Lonza Group, New England Biolabs,

NOTE: Our final report will be revised to address COVID-19 effects on the specific market.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/47794

All key regions and countries are assessed here on the basis of company, type of product, and application covering: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Segment by type, the market is segmented into: CRISPR, TALEN, ZFN, Antisense, Other Technology

Segment by application, the market is segmented into: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Other,

Moreover, the report highlights external as well as internal factors that are expected to affect the global Genome Editing/Genome Engineering industry positively or negatively. PORTER, PESTEL analysis with the potential impact of economic factors by region on the global market is given in the report. Then, the demand-side factors are assessed and shifts in demand patterns across different sub-segments and regions are examined. It also delivers comprehensive information on raw materials suppliers, equipment suppliers, manufacturing cost, capacity, production, profit margin, capacity utilization rate, etc.

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/47794/global-genome-editinggenome-engineering-market-2020-by-company-regions-type-and-application-forecast-to-2026

The Report Provides The Following Information:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketsandresearch.biz

Continued here:
Global Genome Editing/Genome Engineering Market 2020 by Company, Regions, Type and Application, Forecast to 2026 - 3rd Watch News

Read More...

Swine Circovirus Vaccine Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026 – 3rd Watch…

May 27th, 2020 12:09 pm

The market research report is a brilliant, complete, and much-needed resource for companies, stakeholders, and investors interested in the global Swine Circovirus Vaccine market. It informs readers about key trends and opportunities in the global Swine Circovirus Vaccine market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global Swine Circovirus Vaccine market.

Key companies operating in the global Swine Circovirus Vaccine market include Chopper Biology, ChengDu Tecbond, Ringpu Biology, Qilu Animal, DHN, CAVAC, Komipharm, Jinyu Bio-Technology, Zoetis, Merial, etc.

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1777181/covid-19-impact-on-swine-circovirus-vaccine-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Swine Circovirus Vaccine market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Swine Circovirus Vaccine Market Segment By Type:

, Genetic Engineering Vaccine, Killed Vaccines

Global Swine Circovirus Vaccine Market Segment By Application:

,Piglets,Adults Pigs

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Swine Circovirus Vaccine market.

Key companies operating in the global Swine Circovirus Vaccine market include Chopper Biology, ChengDu Tecbond, Ringpu Biology, Qilu Animal, DHN, CAVAC, Komipharm, Jinyu Bio-Technology, Zoetis, Merial, etc.

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1777181/covid-19-impact-on-swine-circovirus-vaccine-market

TOC

1.1 Research Scope1.2 Market Segmentation1.3 Research Objectives1.4 Research Methodology1.4.1 Research Process1.4.2 Data Triangulation1.4.3 Research Approach1.4.4 Base Year1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections1.5.2 Covid-19 Impact: Commodity Prices Indices1.5.3 Covid-19 Impact: Global Major Government Policy1.6 The Covid-19 Impact on Swine Circovirus Vaccine Industry1.7 COVID-19 Impact: Swine Circovirus Vaccine Market Trends 2 Global Swine Circovirus Vaccine Quarterly Market Size Analysis2.1 Swine Circovirus Vaccine Business Impact Assessment COVID-192.1.1 Global Swine Circovirus Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-20262.1.2 Global Swine Circovirus Vaccine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-20262.2 Global Swine Circovirus Vaccine Quarterly Market Size 2020-20212.3 COVID-19-Driven Market Dynamics and Factor Analysis2.3.1 Drivers2.3.2 Restraints2.3.3 Opportunities2.3.4 Challenges 3 Quarterly Competitive Assessment, 20203.1 Global Swine Circovirus Vaccine Quarterly Market Size by Manufacturers, 2019 VS 20203.2 Global Swine Circovirus Vaccine Factory Price by Manufacturers3.3 Location of Key Manufacturers Swine Circovirus Vaccine Manufacturing Factories and Area Served3.4 Date of Key Manufacturers Enter into Swine Circovirus Vaccine Market3.5 Key Manufacturers Swine Circovirus Vaccine Product Offered3.6 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Swine Circovirus Vaccine Segments, By Type4.1 Introduction1.4.1 Genetic Engineering Vaccine1.4.2 Killed Vaccines4.2 By Type, Global Swine Circovirus Vaccine Market Size, 2019-20214.2.1 By Type, Global Swine Circovirus Vaccine Market Size by Type, 2020-20214.2.2 By Type, Global Swine Circovirus Vaccine Price, 2020-2021 5 Impact of Covid-19 on Swine Circovirus Vaccine Segments, By Application5.1 Overview5.5.1 Piglets5.5.2 Adults Pigs5.2 By Application, Global Swine Circovirus Vaccine Market Size, 2019-20215.2.1 By Application, Global Swine Circovirus Vaccine Market Size by Application, 2019-20215.2.2 By Application, Global Swine Circovirus Vaccine Price, 2020-2021 6 Geographic Analysis6.1 Introduction6.2 North America6.2.1 Macroeconomic Indicators of US6.2.2 US6.2.3 Canada6.3 Europe6.3.1 Macroeconomic Indicators of Europe6.3.2 Germany6.3.3 France6.3.4 UK6.3.5 Italy6.4 Asia-Pacific6.4.1 Macroeconomic Indicators of Asia-Pacific6.4.2 China6.4.3 Japan6.4.4 South Korea6.4.5 India6.4.6 ASEAN6.5 Rest of World6.5.1 Latin America6.5.2 Middle East and Africa 7 Company Profiles7.1 Chopper Biology7.1.1 Chopper Biology Business Overview7.1.2 Chopper Biology Swine Circovirus Vaccine Quarterly Production and Revenue, 20207.1.3 Chopper Biology Swine Circovirus Vaccine Product Introduction7.1.4 Chopper Biology Response to COVID-19 and Related Developments7.2 ChengDu Tecbond7.2.1 ChengDu Tecbond Business Overview7.2.2 ChengDu Tecbond Swine Circovirus Vaccine Quarterly Production and Revenue, 20207.2.3 ChengDu Tecbond Swine Circovirus Vaccine Product Introduction7.2.4 ChengDu Tecbond Response to COVID-19 and Related Developments7.3 Ringpu Biology7.3.1 Ringpu Biology Business Overview7.3.2 Ringpu Biology Swine Circovirus Vaccine Quarterly Production and Revenue, 20207.3.3 Ringpu Biology Swine Circovirus Vaccine Product Introduction7.3.4 Ringpu Biology Response to COVID-19 and Related Developments7.4 Qilu Animal7.4.1 Qilu Animal Business Overview7.4.2 Qilu Animal Swine Circovirus Vaccine Quarterly Production and Revenue, 20207.4.3 Qilu Animal Swine Circovirus Vaccine Product Introduction7.4.4 Qilu Animal Response to COVID-19 and Related Developments7.5 DHN7.5.1 DHN Business Overview7.5.2 DHN Swine Circovirus Vaccine Quarterly Production and Revenue, 20207.5.3 DHN Swine Circovirus Vaccine Product Introduction7.5.4 DHN Response to COVID-19 and Related Developments7.6 CAVAC7.6.1 CAVAC Business Overview7.6.2 CAVAC Swine Circovirus Vaccine Quarterly Production and Revenue, 20207.6.3 CAVAC Swine Circovirus Vaccine Product Introduction7.6.4 CAVAC Response to COVID-19 and Related Developments7.7 Komipharm7.7.1 Komipharm Business Overview7.7.2 Komipharm Swine Circovirus Vaccine Quarterly Production and Revenue, 20207.7.3 Komipharm Swine Circovirus Vaccine Product Introduction7.7.4 Komipharm Response to COVID-19 and Related Developments7.8 Jinyu Bio-Technology7.8.1 Jinyu Bio-Technology Business Overview7.8.2 Jinyu Bio-Technology Swine Circovirus Vaccine Quarterly Production and Revenue, 20207.8.3 Jinyu Bio-Technology Swine Circovirus Vaccine Product Introduction7.8.4 Jinyu Bio-Technology Response to COVID-19 and Related Developments7.9 Zoetis7.9.1 Zoetis Business Overview7.9.2 Zoetis Swine Circovirus Vaccine Quarterly Production and Revenue, 20207.9.3 Zoetis Swine Circovirus Vaccine Product Introduction7.9.4 Zoetis Response to COVID-19 and Related Developments7.10 Merial7.10.1 Merial Business Overview7.10.2 Merial Swine Circovirus Vaccine Quarterly Production and Revenue, 20207.10.3 Merial Swine Circovirus Vaccine Product Introduction7.10.4 Merial Response to COVID-19 and Related Developments 8 Supply Chain and Sales Channels Analysis8.1 Swine Circovirus Vaccine Supply Chain Analysis8.1.1 Swine Circovirus Vaccine Supply Chain Analysis8.1.2 Covid-19 Impact on Swine Circovirus Vaccine Supply Chain8.2 Distribution Channels Analysis8.2.1 Swine Circovirus Vaccine Distribution Channels8.2.2 Covid-19 Impact on Swine Circovirus Vaccine Distribution Channels8.2.3 Swine Circovirus Vaccine Distributors8.3 Swine Circovirus Vaccine Customers 9 Key Findings 10 Appendix10.1 About Us10.2 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

View original post here:
Swine Circovirus Vaccine Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026 - 3rd Watch...

Read More...

Amid the COVID-19 crisis and the looming economic recession, the D-Amino Acids market worldwide will grow by a projected US$49.4 Million, during the…

May 27th, 2020 12:09 pm

New York, May 27, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global D-Amino Acids Industry" - https://www.reportlinker.com/p05621748/?utm_source=GNW 7 Million by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Pharmaceutical market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 2.3% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$1.2 Million to the regions size over the next 7 to 8 years. In addition, over US$1.2 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Pharmaceutical segment will reach a market size of US$8.6 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the D-Amino Acids market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the worlds second largest economy will grow at 6.9% over the next couple of years and add approximately US$15.9 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing D-Amino Acids market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, GoPro, Inc.; Infineon Technologies AG; Intel Corporation; Kula 3D Ltd.; LG Electronics; Matter and Form Inc.; Microsoft Corp.; pmdtechnologies GmbH; Samsung Electronics Co., Ltd.; Sharp Corporation; Texas Instruments Inc.; Toshiba Corporation

Read the full report: https://www.reportlinker.com/p05621748/?utm_source=GNW

D-AMINO ACIDS MCP-7MARKET ANALYSIS, TRENDS, AND FORECASTS, JUNE 2CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW D-Amino Acids: A Compound with Promising Applications Recent Market Activity Developing Regions - At the Forefront of Growth in D-Amino Acids Market Pharmaceuticals: D-Amino Acids Hold Edge as Essential Raw Material Rising Prominence of Artificial Amino Acids Augurs Well for Market Growth Global Competitor Market Shares D-Amino Acids Competitor Market Share Scenario Worldwide (in %): 2020 & 2029 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS Adisseo France S.A.S (France) Ajinomoto Co., Inc. (Japan) AnaSpec, Inc. (USA) Evonik Industries AG (Germany) IRIS Biotech GmbH (Germany) LifeSpan Biosciences, Inc. (USA) Merck KGaA (Germany) Sekisui Medical Co., Ltd. (Japan) Shanghai Hanhong Chemical Co., Ltd. (China) Sichuan Tongsheng Amino acid Co., Ltd. (China) Sumitomo Chemical Company Limited (Japan) TCI America, Inc. (USA) Tocris Bioscience (UK) Zhangjiagang Huachang Pharmaceutical Co., Ltd. (China) 3. MARKET TRENDS & DRIVERS Aging World Population - A Major Growth Influencing Factor for D-Amino Acids Growing Importance of D-Amino Acids in Pharmaceutical Industry Peptide-based Drugs: A Promising Area for D-Amino Acids Growing Interest in Peptide Research Drives D-Amino Acids Market Pharmaceutical Intermediates Market Challenged by Drug Development A Review of Select Research Studies on D-Amino Acids Research Finds Support for Potential Use of D-Amino Acids as Biomarkers for CKD D-Amino Acids and Small Molecule Inhibitors: Potential Role in Eliminating Infections Researchers Develop New Approach to Switch Chirality in Amino Acids Generating Stable D-Amino Acid Analogs Using Mirror Image Version of PDB Ajinomoto Develops Ajiphase and Corynex Amino Acid Synthesis Technologies Harvard University's Scientists Discover New Biofilm Disrupting Bacteria Study Reveals that D-Amino Acids Amass in EMCs Research Studies Suggest that Replacement of One L-Amino Acid with Analogous D-enantiomer Results in High Therapeutic Index ARCA: A Breakthrough Chiral Converting Agent for Amino Acids Commercial Development of ARCA Genetic Engineering and Advances in Research Enable DAAO Use in Multiple Arenas DL-Methionine: An Eco-Friendly Option for Animal Nutrition 4. GLOBAL MARKET PERSPECTIVE Table 1: D-Amino Acids Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 2: D-Amino Acids Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019 Table 3: D-Amino Acids Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Pharmaceutical (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027 Table 5: Pharmaceutical (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019 Table 6: Pharmaceutical (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: Industrial (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027 Table 8: Industrial (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019 Table 9: Industrial (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 Table 10: Other End-Uses (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 11: Other End-Uses (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019 Table 12: Other End-Uses (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US D-Amino Acids Market Share (in %) by Company: 2020 & 2025 Market Analytics Table 13: United States D-Amino Acids Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027 Table 14: D-Amino Acids Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2012-2019 Table 15: D-Amino Acids Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027 CANADA Table 16: Canadian D-Amino Acids Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 Table 17: D-Amino Acids Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019 Table 18: Canadian D-Amino Acids Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 JAPAN Table 19: Japanese Demand Estimates and Forecasts for D-Amino Acids in US$ Thousand by End-Use: 2020 to 2027 Table 20: Japanese D-Amino Acids Market in US$ Thousand by End-Use: 2012-2019 Table 21: D-Amino Acids Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027 CHINA Table 22: Chinese Demand for D-Amino Acids in US$ Thousand by End-Use: 2020 to 2027 Table 23: D-Amino Acids Market Review in China in US$ Thousand by End-Use: 2012-2019 Table 24: Chinese D-Amino Acids Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 EUROPE Market Facts & Figures European D-Amino Acids Market: Competitor Market Share Scenario (in %) for 2020 & 2025 Market Analytics Table 25: European D-Amino Acids Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027 Table 26: D-Amino Acids Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019 Table 27: European D-Amino Acids Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 28: European D-Amino Acids Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 Table 29: D-Amino Acids Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019 Table 30: European D-Amino Acids Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 FRANCE Table 31: D-Amino Acids Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027 Table 32: French D-Amino Acids Historic Market Review in US$ Thousand by End-Use: 2012-2019 Table 33: French D-Amino Acids Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 GERMANY Table 34: D-Amino Acids Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027 Table 35: German D-Amino Acids Market in Retrospect in US$ Thousand by End-Use: 2012-2019 Table 36: D-Amino Acids Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027 ITALY Table 37: Italian Demand for D-Amino Acids in US$ Thousand by End-Use: 2020 to 2027 Table 38: D-Amino Acids Market Review in Italy in US$ Thousand by End-Use: 2012-2019 Table 39: Italian D-Amino Acids Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 UNITED KINGDOM Table 40: United Kingdom Demand Estimates and Forecasts for D-Amino Acids in US$ Thousand by End-Use: 2020 to 2027 Table 41: United Kingdom D-Amino Acids Market in US$ Thousand by End-Use: 2012-2019 Table 42: D-Amino Acids Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027 SPAIN Table 43: Spanish D-Amino Acids Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 Table 44: D-Amino Acids Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019 Table 45: Spanish D-Amino Acids Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 RUSSIA Table 46: Russian D-Amino Acids Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027 Table 47: D-Amino Acids Historic Demand Patterns in Russia by End-Use in US$ Thousand for 2012-2019 Table 48: D-Amino Acids Market Share Breakdown in Russia by End-Use: 2012 VS 2020 VS 2027 REST OF EUROPE Table 49: Rest of Europe D-Amino Acids Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 Table 50: D-Amino Acids Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019 Table 51: Rest of Europe D-Amino Acids Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 52: Asia-Pacific D-Amino Acids Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 53: D-Amino Acids Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019 Table 54: Asia-Pacific D-Amino Acids Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 Table 55: D-Amino Acids Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027 Table 56: Asia-Pacific D-Amino Acids Historic Market Review in US$ Thousand by End-Use: 2012-2019 Table 57: Asia-Pacific D-Amino Acids Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 AUSTRALIA Table 58: D-Amino Acids Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027 Table 59: Australian D-Amino Acids Market in Retrospect in US$ Thousand by End-Use: 2012-2019 Table 60: D-Amino Acids Market Share Distribution in Australia by End-Use: 2012 VS 2020 VS 2027 INDIA Table 61: Indian D-Amino Acids Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 Table 62: D-Amino Acids Market in India: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019 Table 63: Indian D-Amino Acids Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 SOUTH KOREA Table 64: D-Amino Acids Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by End-Use for the Period 2020-2027 Table 65: South Korean D-Amino Acids Historic Market Analysis in US$ Thousand by End-Use: 2012-2019 Table 66: D-Amino Acids Market Share Distribution in South Korea by End-Use: 2012 VS 2020 VS 2027 REST OF ASIA-PACIFIC Table 67: Rest of Asia-Pacific Demand Estimates and Forecasts for D-Amino Acids in US$ Thousand by End-Use: 2020 to 2027 Table 68: Rest of Asia-Pacific D-Amino Acids Market in US$ Thousand by End-Use: 2012-2019 Table 69: D-Amino Acids Market Share Shift in Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027 LATIN AMERICA Table 70: Latin American D-Amino Acids Market Trends by Region/Country in US$ Thousand: 2020-2027 Table 71: D-Amino Acids Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019 Table 72: Latin American D-Amino Acids Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 Table 73: Latin American Demand for D-Amino Acids in US$ Thousand by End-Use: 2020 to 2027 Table 74: D-Amino Acids Market Review in Latin America in US$ Thousand by End-Use: 2012-2019 Table 75: Latin American D-Amino Acids Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 ARGENTINA Table 76: Argentinean D-Amino Acids Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 Table 77: D-Amino Acids Market in Argentina: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019 Table 78: Argentinean D-Amino Acids Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 BRAZIL Table 79: D-Amino Acids Quantitative Demand Analysis in Brazil in US$ Thousand by End-Use: 2020-2027 Table 80: Brazilian D-Amino Acids Historic Market Review in US$ Thousand by End-Use: 2012-2019 Table 81: Brazilian D-Amino Acids Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 MEXICO Table 82: D-Amino Acids Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027 Table 83: Mexican D-Amino Acids Market in Retrospect in US$ Thousand by End-Use: 2012-2019 Table 84: D-Amino Acids Market Share Distribution in Mexico by End-Use: 2012 VS 2020 VS 2027 REST OF LATIN AMERICA Table 85: Rest of Latin America D-Amino Acids Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027 Table 86: D-Amino Acids Historic Demand Patterns in Rest of Latin America by End-Use in US$ Thousand for 2012-2019 Table 87: D-Amino Acids Market Share Breakdown in Rest of Latin America by End-Use: 2012 VS 2020 VS 2027 MIDDLE EAST Table 88: The Middle East D-Amino Acids Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 89: D-Amino Acids Market in the Middle East by Region/Country in US$ Thousand: 2012-2019 Table 90: The Middle East D-Amino Acids Market Share Breakdown by Region/Country: 2012, 2020, and 2027 Table 91: The Middle East D-Amino Acids Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 Table 92: D-Amino Acids Market in the Middle East: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019 Table 93: The Middle East D-Amino Acids Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 IRAN Table 94: Iranian Demand Estimates and Forecasts for D-Amino Acids in US$ Thousand by End-Use: 2020 to 2027 Table 95: Iranian D-Amino Acids Market in US$ Thousand by End-Use: 2012-2019 Table 96: D-Amino Acids Market Share Shift in Iran by End-Use: 2012 VS 2020 VS 2027 ISRAEL Table 97: Israeli D-Amino Acids Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 Table 98: D-Amino Acids Market in Israel: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019 Table 99: Israeli D-Amino Acids Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 SAUDI ARABIA Table 100: Saudi Arabian Demand for D-Amino Acids in US$ Thousand by End-Use: 2020 to 2027 Table 101: D-Amino Acids Market Review in Saudi Arabia in US$ Thousand by End-Use: 2012-2019 Table 102: Saudi Arabian D-Amino Acids Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 UNITED ARAB EMIRATES Table 103: D-Amino Acids Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by End-Use for the Period 2020-2027 Table 104: United Arab Emirates D-Amino Acids Historic Market Analysis in US$ Thousand by End-Use: 2012-2019 Table 105: D-Amino Acids Market Share Distribution in United Arab Emirates by End-Use: 2012 VS 2020 VS 2027 REST OF MIDDLE EAST Table 106: D-Amino Acids Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027 Table 107: Rest of Middle East D-Amino Acids Market in Retrospect in US$ Thousand by End-Use: 2012-2019 Table 108: D-Amino Acids Market Share Distribution in Rest of Middle East by End-Use: 2012 VS 2020 VS 2027 AFRICA Table 109: African D-Amino Acids Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027 Table 110: D-Amino Acids Historic Demand Patterns in Africa by End-Use in US$ Thousand for 2012-2019 Table 111: D-Amino Acids Market Share Breakdown in Africa by End-Use: 2012 VS 2020 VS 2027 IV. COMPETITION

Total Companies Profiled: 31 Read the full report: https://www.reportlinker.com/p05621748/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Read the rest here:
Amid the COVID-19 crisis and the looming economic recession, the D-Amino Acids market worldwide will grow by a projected US$49.4 Million, during the...

Read More...

Lessons From Operation "Denver," the KGB’s Massive AIDS Disinformation Campaign – The MIT Press Reader

May 27th, 2020 12:09 pm

Historian Douglas Selvage sheds light on a conspiracy theory that reverberates to this day.

By: Mark Kramer

In September 1985, the Soviet State Security Committee (KGB) informed other Warsaw Pact foreign intelligence agencies that it had launched a new, major disinformation campaign. We are carrying out a complex of [active] measures in connection with the appearance in recent years of a new dangerous disease in the USA known as AIDS (Acquired Immunodeficiency Syndrome). The KGB explained that the goal of the measures is to create a favorable opinion for us abroad namely, that this disease is the result of secret experiments by the USAs secret services and the Pentagon with new types of biological weapons that have spun out of control. Most likely, the KGB had initiated the disinformation campaign as early as 1983, but the September 1985 document obtained by Christopher Nehring from the former Bulgarian State Security archive is the earliest conclusive evidence that has turned up so far. (The former KGB foreign intelligence archive has never been accessible to researchers.)

Among the East European intelligence services that assisted the KGB in this effort was the East German Ministry for State Security (Stasi), which used the codename Denver when referring to the campaign. The KGB and Stasi relied on forged documents and inaccurate testimony from purported experts to suggest that HIV, the virus that causes AIDS, had originated not from infected animals in Africa but from biological warfare research carried out by U.S. military scientists at Fort Detrick in Maryland. Operation Denver proved remarkably effective, writes historian Douglas Selvage in an article featured in a recent issue of the Journal of Cold War Studies; indeed, even more effective than the KGB and Stasi had originally expected. Before long, immense numbers of people around the world (including in the United States) came to believe, falsely, that the U.S. government was responsible for AIDS.

The conspiracy theories circulating in 2020 are more diffuse and less coherent than the disinformation propagated by the KGB and the Stasi in the 1980s, but the two periods bear distinct similarities.

Selvages article appeared a few months before Covid-19 burst into public consciousness. The Covid-19 pandemic has provoked a wide range of lurid conspiracy theories in countries whose governments are hostile to the United States, notably Russia, China, Iran, and Venezuela. The conspiracy theories circulating in 2020 are more diffuse and less coherent than the disinformation propagated by the KGB and the Stasi in the 1980s, but the two periods bear distinct similarities. In both cases, authoritarian regimes have exploited widespread public fear and confusion to generate suspicions about U.S. motives, to stoke hostility toward the United States, and to discredit the U.S. governments sincerity in combatting the global pandemic.

In our exchange featured below, Selvage sheds light on the origins and main purpose of operation Denver and considers the lessons we may learn in responding to Russian and Chinese disinformation in 2020.

Mark Kramer: The Soviet KGB was the agency that originated the AIDS disinformation campaign, but the KGB enlisted the East German Stasi early on to help out. To what extent did other Soviet-bloc intelligence agencies also participate? Did the Stasi play the lead role after the Soviet KGB?

Douglas Selvage: Based on statements by KGB and Stasi officers to their Bulgarian counterparts in 1986-9, the Stasis foreign intelligence branch (Hauptverwaltung Aufklrung, HVA) played a central role in the disinformation campaign alongside the KGB. Bulgarian and especially Czechoslovak foreign intelligence also assisted, but mainly in terms of spreading leaflets around U.S. military bases and encouraging stories in the local press in NATO countries. These claimed (falsely) that U.S. service members suffered a high infection rate with HIV and were spreading AIDS locally around U.S. military bases. The Cuban government also played a role in spreading AIDS disinformation about the U.S. in Latin America, but the details remain unclear.

M.K.: Why did the Stasi give the codename Denver to the disinformation campaign?

D.S.: We actually do not know why the Stasi chose this particular codename because the HVA destroyed around 90 percent of its records in 1989-90, including the files for Operation Denver. One can only speculate. It is possible that a Stasi officer heard the term Fort Detrick and thought Denver instead of Detrick that is, a geographical term more familiar to most Germans. At the time, a popular program on West German television, also viewed in East Germany, was Denver-Clan, the German name for the popular U.S. television series Dynasty. But this is all just speculation. As early as 1987, the Stasi officers responsible for the AIDS disinformation campaign began using the terms Denver and Detrick interchangeably in talks with their Bulgarian counterparts. The use of Denver had apparently created some confusion.

One term that never came up in talks between the Stasi and their Bulgarian counterparts, let alone in talks between the KGB and the Bulgarians, was Operation Infektion. Despite this fact, practically the entire internet continues to use this incorrect codename in discussing the KGBs AIDS disinformation campaign. The New York Times even decided to use it as the title for its series of popular videos about Soviet and Russian disinformation.

M.K.: What was the main purpose of Operation Denver? What were the main types of disinformation activities?

D.S.: The KGB informed its Bulgarian colleagues in September 1985 that it had initiated a campaign of active measures that is, covert propaganda regarding HIV/AIDS. The goal of these measures, the KGB wrote, is to create a favorable opinion for us abroad that this disease is the result of secret experiments with a new type of biological weapon by the secret services of the USA and the Pentagon that spun out of control. Around a year later, the Stasi wrote to the Bulgarians about Operation Denver, its contribution to the KGBs AIDS disinformation campaign. Through the operation, the Stasi sought to expose the dangers to mankind arising from the research, production, and use of biological weapons, to strengthen anti-American sentiments in the world, and to spark domestic political controversies in the USA. To this end, the Stasi promised to provide their Bulgarian comrades with a scientific study and other materials that prove that AIDS originated in the USA, not in Africa, and that AIDS is a product of the USAs bioweapons research.

Through the operation, the Stasi sought to expose the dangers to mankind arising from the research, production, and use of biological weapons, to strengthen anti-American sentiments in the world, and to spark domestic political controversies in the USA.

The scientific study to which the Stasi referred was clearly AIDS: Its Nature and Origin by the retired Soviet-East German biologist Jakob Segal and his wife, Lilli, a scientist and author in her own right. The Stasi claimed to have played a role in photocopying and distributing the study in a brochure entitled, AIDS: USA home-made evil, NOT out of AFRICA at a summit meeting of the Non-Aligned Movement in Harare, Zimbabwe in August-September 1986. This was a gathering of world leaders, mainly from the less-developed countries, that had proclaimed their neutrality in the superpower rivalry during the Cold War. Journalists, especially from Africa, reported on the Segals findings. The Segals were claiming just like the KGB, but on the basis of a more scientific analysis that HIV had leaked out of a U.S. military biological-weapons research lab at Fort Detrick, Maryland. The U.S. military, the Segals claimed, had used the very new technology of genetic engineering to construct HIV from two other dangerous viruses, including one that infected sheep.

Many leaders, journalists, and intellectuals in Africa welcomed the Segals thesis of a U.S. origin of HIV as an alternative to the hypothesis of many leading U.S. and Western scientists at the time. The latter were arguing correctly, as it later turned out that HIV had originated in Africa, where it had spread from non-human primates to human beings. Many Africans interpreted this hypothesis, especially given the scant evidence at the time, as an attempt to blame Africa and Africans for HIV/AIDS. In the weeks following the Harare summit, the Segals Fort-Detrick-thesis of AIDS origins spread throughout the press in Africa, India, and the world.

The Stasi apparently helped behind the scenes in bringing the Segals together with certain foreign journalists who were known quantities to its disinformation division. The official Soviet press agency Novosti also helped to spread the thesis abroad, alongside the KGB. The KGB happily noted that foreign journalists, without any prompting on its part, were also picking up on the claims and reporting them. For example, officials from the Reagan Administration were perturbed that Dan Rather reported the Soviets accusations about AIDS and Fort Detrick on the CBS Evening News in 1987 without requesting a U.S. government response.

The Stasi apparently helped behind the scenes in bringing the Segals together with certain foreign journalists who were known quantities to its disinformation division.

The Stasi also claimed to have covertly co-financed a documentary film shown three times on public-financed West German television in 1989 and subsequently in an English version on British Channel Four in 1990. The film featured an interview with the Segals, who expounded upon their thesis; conversations with journalists and African scientists, who denounced the hypothesis of a natural origin of AIDS in Africa as racist; and U.S. and Western critics of the ostensibly defensive U.S. biological-weapons research program. (No mention was made of the Soviet Unions much larger, offensive biological-weapons research program, but little was publicly known about it at the time.)

The two co-creators of the West German film strenuously deny that the Stasi covertly financed the film or was involved with it in any other way. They also deny that they ever had any contacts to the Stasi. Whatever the case may be, officers from the Stasis disinformation division, ostensibly convinced that the film contributed to their goals for Operation Denver, encouraged Bulgarian and apparently also Czechoslovak foreign intelligence to covertly support the sale and distribution of the films German and English versions in non-communist countries.

The German film or perhaps a bootleg version can still be viewed on YouTube today.

M.K.: When you began writing about the Soviet-East German AIDS disinformation campaign, did you ever imagine that you might live through a global pandemic that would give rise to lurid conspiracy theories in Russia, China, and Iran claiming that the deadly pathogen was manufactured in U.S. biological defense laboratories?

D.S.: Strangely, in retrospect, I did not imagine living through another global pandemic in my lifetime, despite the warnings of the Obama Administration and the example of the HIV/AIDS pandemic. Many more of us should have known better.

Still, as a historian, I am not surprised that conspiracy theories would arise in response to the Covid-19 pandemic. Since the Middle Ages, if not long before, people have responded to epidemics and pandemics by trying to find a responsible party or parties, often in the form of a scapegoat. For example, some Christians in Europe blamed the Jews for the bubonic plague and responded with violence and murder.

Since the Middle Ages, if not long before, people have responded to epidemics and pandemics by trying to find a responsible party or parties, often in the form of a scapegoat.

Often, victims of repression and real conspiracies also respond with suspicion to pandemics and other disasters, and to explain the seemingly inexplicable, they craft conspiracy theories. For example, the KGB was not the first to accuse the U.S. government of constructing the AIDS virus. Already in 1983, some members of the gay community in the U.S. had accused the federal government of constructing the virus in order to kill off gay Americans. This came at least partly in response to their frustration with decades of discrimination, the accelerating death toll from HIV/AIDS, and the lagging, at times callous, response of the Reagan Administration to the pandemic. As it became clear that African-Americans were also suffering disproportionately from the disease, some African-Americans came to believe in and spread similar conspiracy theories. Such accusations seemed plausible to many, given the history of racism in the United States, including in the medical field. One particularly reprehensible episode was the Tuskegee syphilis study, in which the U.S. Public Health Service had observed the long-term effects of syphilis on infected African-American sharecroppers and their offspring for four decades, from 1932 to 1972, without providing them with effective medical treatment, even after penicillin had proven effective against the disease.

Of course, political extremists, in and out of power, often develop or exploit conspiracy theories to their own ends. In my article for the Journal of Cold War Studies, I demonstrate how the perennial right-wing U.S. Presidential candidate Lyndon LaRouche and his organization promoted a variant of the AIDS-from-Fort-Detrick thesis. They promoted the claim that a Soviet fifth column had infiltrated the National Institutes of Health through the World Health Organization and then genetically engineered the AIDS virus at the National Cancer Institutes facilities at Fort Detrick. Although LaRouches organization counter-attacked the KGB disinformation with its own version of the Fort Detrick thesis, and the KGB and Moscow attacked LaRouche, both apparently borrowed elements from each others conspiracy theory in constructing their own.

A cycle of misinformation and disinformation arose in which the KGB cited U.S. conspiracy theories, and U.S. conspiracy theorists, in turn, began to cite texts associated with KGB disinformation.

In the case of the AIDS disinformation campaign, the KGB simply picked up on existing conspiracy theories in the U.S, added a new element that conformed to its disinformation goals (i.e., the exact location of HIVs construction, Fort Detrick), and spread the resulting conspiracy theory internationally to its own ends. A cycle of misinformation and disinformation arose in which the KGB cited U.S. conspiracy theories, and U.S. conspiracy theorists, in turn, began to cite texts associated with KGB disinformation.

One can see a similar dynamic today between Russian disinformation and U.S. conspiracy theorists if one closely views Sputnik News and RT (formerly Russia Today) on Twitter and Facebook. Already during the Ebola epidemic in West Africa in 2013-16, these Russian propaganda outlets spread reports that the virus had been created by the U.S. in collaboration with Great Britain and South Africa in order to kill off Africans. That is, different virus, similar disinformation. So, it did not surprise me that certain propagandists in Russia spread similar rumors about the origin of Covid-19. Since I knew less about Chinese disinformation efforts, it surprised me that Beijing apparently decided to revamp the old, Soviet disinformation and to apply it to the new virus.

M.K.: What are the lessons we can learn from Operation Denver in responding to the Russian and Chinese disinformation now?

D.S.: During the Cold War, the Reagan Administration had an Active Measures Working Group that exposed and publicized examples of Soviet disinformation. It was particularly active in combatting the Soviet blocs AIDS disinformation. Over the long term, the ongoing exposure of Soviet disinformation efforts sparked a backlash internationally, helped discredit Soviet propaganda agencies and created effective pressure on the Soviet Union to curtail or at least to limit its activities. A similar, intensive effort by the U.S. and other democracies could also prove effective today. NATO allies such as Estonia have adopted such measures, but the U.S. is lagging behind.

From my perspective, it would be even more important, especially for the long term, to train students as early as elementary school to differentiate between facts and opinions and to identify not only propaganda techniques, but also fallacies in logic. There were some initiatives in this regard during the Cold War in the United States. I dont know if they still continue today. Students and others would also benefit from training in internet literacy: What sources can one trust, and how can one fact-check various claims, especially before reposting them?

Students and others would also benefit from training in internet literacy: What sources can one trust, and how can one fact-check various claims, especially before reposting them?

There is one thing that democratic governments should definitely avoid in responding to disinformation namely, spreading conspiracy theories and disinformation themselves. Of course, during the Cold War, the U.S. and other democracies did this, if not to the same extent as the Soviet Union and its allies.

Today, it absolutely does not help, for example, when the Trump Administration and other U.S. politicians openly promote their own conspiracy theories about Covid-19, including basically unsubstantiated claims that the virus escaped from a Chinese laboratory in Wuhan. This leads to fruitless public discussion along the lines of: Who was responsible for constructing the virus China or the U.S.? Such apparently baseless accusations also make the public, especially in third countries, less willing to listen to other, substantiated criticisms of Chinas response to the pandemic, including its initial suppression of warnings from doctors in Wuhan. The Chinese government has succeeded to some extent in lumping together accusations about the Wuhan laboratory with all other criticisms of its role and response to the pandemic as mere China-bashing.

The promotion of conspiracy theories regarding a viruss origins can also undermine public health efforts to mitigate its spread and save lives. Studies show that individuals who believe in conspiracy theories regarding the origins of HIV/AIDS are less likely to follow medical advice regarding safe sex, to test themselves for potential infection, or to take effective medications to contain the disease. Such behaviors, of course, can lead to death. Apparently, believers in HIV/AIDS conspiracy theories reason as follows: If scientists and medical doctors cannot be trusted to tell the truth or have been duped themselves about a viruss origins, why should one trust their medical or public health advice? Not surprisingly, there are also individuals who have turned a profit by selling publications with their own versions of the HIV/AIDS conspiracy theory alongside their own unproven, alternative therapies for the disease. In the case of HIV/AIDS, such quack therapies have included aspirin, alfa-interferon, the ultraviolet irradiation of blood, vitamin cocktails, traditional Chinese or African herbs, and colloidal silver. With regard to Covid-19 today, we see the spread of similar conspiratorial beliefs, an associated rejection of public health measures, and a similar propagation of unproven and potentially dangerous alternative therapies.

With regard to Covid-19 today, we see the spread of similar conspiratorial beliefs, an associated rejection of public health measures, and a similar propagation of unproven and potentially dangerous alternative therapies.

The example of the response to the HIV/AIDS pandemic by the democratically-elected government of South Africa under President Thabo Mbeki (1999-2008) should serve as a warning to us today as we grapple with Covid-19. He and his health minister came to believe in various conspiracy theories regarding HIV/AIDS from the internet, including the Fort Detrick thesis. They thus rejected the mainstream medical science on HIV/AIDS and came to promote various unproven alternative therapies some mentioned above for treating the disease. It has been estimated that the ensuing delay in the introduction of effective antiretroviral treatment for HIV/AIDS in South Africa contributed to up to 300,000 additional deaths from the disease.

Mark Kramer is director of Cold War Studies at Harvard Universitys Davis Center for Russian and Eurasian Studies, and the editor of the Journal of Cold War Studies.

Douglas Selvage is a Research Associate (wissenschaftlicher Mitarbeiter) at the Institute for History of the Humboldt University in Berlin.

See the original post here:
Lessons From Operation "Denver," the KGB's Massive AIDS Disinformation Campaign - The MIT Press Reader

Read More...

COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2020-2026 – Jewish Life News

May 27th, 2020 12:06 pm

In this report, the COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2019 and 2026. COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market has been broken down by major regions, with complete market estimates on the basis of products/applications on a regional basis.

Browse full research report at https://www.crystalmarketreport.com/covid-19-impact-on-global-stem-cell-and-platelet-rich-plasma-prp-alopecia-therapies-market-size-status-and-forecast-2020-2026

Platelet-rich plasma (PRP) has emerged as a new treatment modality in regenerative plastic surgery, and preliminary evidence suggests that it might have a beneficial role in hair regrowth.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies industry.

Based on our recent survey, we have several different scenarios about the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market in terms of revenue.

Players, stakeholders, and other participants in the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

The following players are covered in this report:

Orange County Hair Restoration Center

Hair Sciences Center of Colorado

Anderson Center for Hair

Evolution Hair Loss Institute

Savola Aesthetic Dermatology Center

Virginia Surgical Center

Hair Transplant Institute of Miami

Colorado Surgical Center & Hair Institute

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Breakdown Data by Type

Platelet Rich Plasma Injections

Stem Cell Therapy

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Breakdown Data by Application

Dermatology Clinics

Hospitals

Browse full research report at https://www.crystalmarketreport.com/covid-19-impact-on-global-stem-cell-and-platelet-rich-plasma-prp-alopecia-therapies-market-size-status-and-forecast-2020-2026

Reasons to Buy This Research Report

About Crystal Market Reports

Crystal Market Reports is a distributor of market research spanning 160 industries. Our extensive database consists of over 400,000 quality publications sourced from 400 plus publishers, this puts our research specialists in the unique position of been able to offer truly unbiased advice on what research provides the most valuable insights.

Contact Info.:-

Address: 911 Central Avenue #268Albany New York 12206Email: [emailprotected]Phone: 1-518-730-1569Web: https://www.crystalmarketreport.com

Read the original:
COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2020-2026 - Jewish Life News

Read More...

Global Stem Cell Therapy Market 2020 Top Manufactures, Growth Opportunities and Investment Feasibility 2026 – Surfacing Magazine

May 27th, 2020 12:06 pm

Released by MarketsandResearch.biz, Global Stem Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2026 profoundly explores an overarching research study which talks about the current market scenario. The report explains the overall global Stem Cell Therapy market journey in the previous five years along with the prophecy made by the experts in the industry. The report attributes product innovation, and technological advancements boosting market development in the near future. A comprehensive study of key market dynamics and current trends, along with relevant market sectors and sub-sectors is offered. The report incorporates important factors such as market opportunities, risk, benefit, opportunity, loss, and profit.

Market Overview:

Data associated with the market on the products, strategies and market share of leading companies of this market are mentioned. Detailed understandings into ongoing industry trends, trend prediction, and growth drivers are offered in the report. Additionally, potential market risks, obstacles, threats, and uncertainties are also determined in the report. Market segments examined in the report include major types, applications, regions, and end-users. This research study features the data about the global Stem Cell Therapy market share held by every region with potential growth prospects on the basis of the regional analysis. The research document serves accurate calculation and forecast of sales by type and application in terms of volume and value for the period between 2020 and 2026.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/41722

Competitive rivalry scenario for the global Stem Cell Therapy market: Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCRPharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix),

The study broadly exemplifies, the regional hierarchy of this market, while categorizing the same into: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

On the basis of product, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into: Autologous, Allogeneic

On the basis of application, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into: Musculoskeletal Disorder, Wounds & Injuries, Cornea, Cardiovascular Diseases, Others,

Drivers & Challenges:

The market report delivers information about the driving factors affecting the revenue scale of this global Stem Cell Therapy industry as well as their influence on the commercialization graph of this business sphere. The research study incorporates the latest trends building up the market in conjunction with the challenges that this business vertical will face over the forecast duration. Additionally, it encompasses the obstacles that this industry will be characterized by, in the forecast timeframe.

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/41722/global-stem-cell-therapy-market-2020-by-company-regions-type-and-application-forecast-to-2026

Report Answers Following Questions:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketsandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketsandresearch.bizWeb: http://www.marketsandresearch.biz

Here is the original post:
Global Stem Cell Therapy Market 2020 Top Manufactures, Growth Opportunities and Investment Feasibility 2026 - Surfacing Magazine

Read More...

Global Blood Cell Separator Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 – 3rd Watch News

May 27th, 2020 12:06 pm

In this report, the Global Blood Cell Separator market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2019 and 2026. Global Blood Cell Separator market has been broken down by major regions, with complete market estimates on the basis of products/applications on a regional basis.

Browse full research report at https://www.crystalmarketreport.com/global-blood-cell-separator-industry-research-report-growth-trends-and-competitive-analysis-2020-2026

Blood separator used for blood cell collection: such as peripheral blood stem cell collection, red blood cell collection, platelet collection, white blood cell collection, plasma exchange, etc.At present, it has been successfully used in stem cell transplantation, bone marrow transplantation, platelet and white blood cell transplantation.

Prior to COVID-19, the global market for Blood Cell Separator was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 20212026, whereas post-COVID-19 scenario, the market for Blood Cell Separator is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 20212026. The solicitation of proposals by the governments and publicprivate companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Blood Cell Separator market.

In terms of production side, this report researches the Blood Cell Separator production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.

In terms of consumption side, this report focuses on the consumption of Blood Cell Separator by regions (countries) and by Application.

The global Blood Cell Separator market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Blood Cell Separator market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Blood Cell Separator market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the Blood Cell Separator industry.

Regions and Countries

Regional analysis is another highly comprehensive part of the research and analysis study of the global Blood Cell Separator market presented in the report. This section sheds light on the sales growth of different regional and country-level Blood Cell Separator markets. It includes sales (consumption) analysis and forecast by each application segment and type segment in terms of volume for the period 2015-2020. For the period 2015-2026, it provides detailed and accurate country-wise volume sales analysis and region-wise volume analysis of the global Blood Cell Separator market.

The report offers in-depth assessment of the growth and other aspects of the Blood Cell Separator market in important countries, including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. Key regions covered in the report are North America, Europe and China

Leading Players

The analysts authoring the report have closely analyzed each leading and prominent player of the global Blood Cell Separator market. The competitive analysis section of the report provides a list of players competing at a global level and segregates them according to the type segment of the global Blood Cell Separator market they focus on. It also provides production analysis by the manufacturer for the period 2015-2020. In addition, readers of the report are provided with revenue analysis and price analysis by the manufacturer at a global level for the period 2015-2020. Considering the same period, the market entry year of each player included in the report has been provided.

This report includes the following manufacturers; we can also add the other companies as you want.

Fresenius

Haemonetics Corporation(HAE)

Terumo

Sichuan Medical And Health Rroducts Cosmetics Quality Management Assoclation

Market Segment by Type

Single Component for Blood Transfusion

Therapeutic Blood Components Isolated

Market Segment by Application

Hospital

Blood Collection Station

Others

Browse full research report at https://www.crystalmarketreport.com/global-blood-cell-separator-industry-research-report-growth-trends-and-competitive-analysis-2020-2026

Reasons to Buy This Research Report

About Crystal Market Reports

Crystal Market Reports is a distributor of market research spanning 160 industries. Our extensive database consists of over 400,000 quality publications sourced from 400 plus publishers, this puts our research specialists in the unique position of been able to offer truly unbiased advice on what research provides the most valuable insights.

Contact Info.:-

Address: 911 Central Avenue #268Albany New York 12206Email: [emailprotected]Phone: 1-518-730-1569Web: https://www.crystalmarketreport.com

The rest is here:
Global Blood Cell Separator Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 - 3rd Watch News

Read More...

COVID-19 IMPACT ON Titanium Sponge Market | VOLUME, ANALYSIS, FUTURE PREDICTION, INDUSTRY OVERVIEW AND FORECAST 2025 – Cole of Duty

May 27th, 2020 12:06 pm

Global Titanium Sponge Market is an extensive compilation of in-depth analysis, factual assessments, value chain structure, industrial environment, regional analysis, applications, market size, share, and forecast. The report explains historic and current market status to provide comprehension for forthcoming occurrences in the market. The report provides an overall analysis of the market based on types, applications, regions, and the forecast period from 2020 to 2025. It also offers investment opportunities and probable threats in the market based on an intelligent analysis. The research will help you to depict the entire global Titanium Sponge market through authentic and reliable estimation.

Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE: https://www.mrinsights.biz/report-detail/236091/request-sample

Competitive Landscape:

The report examines the global Titanium Sponge market competition by focusing on leading industry players with information such as company profiles, components, and services offered, financial information of the past years, key developments in the previous years. The study presents the strengths and weaknesses of these companies and provides information about various strategies used by these players. The key strategies used by the leading players such as new products, innovation, expanding business through mergers, acquisitions, and partnerships are highlighted.

The most significant players coated in global Titanium Sponge market report: AVISMA, Luoyang Shuangrui Wanji Titanium, UKTMP, Timet, ATI, ZTMK, Zunyi Titanium, OSAKA Titanium, Pangang Titanium, Toho Titanium, Shanxi Zhuofeng, Chaoyang Jinda, Chaoyang Baisheng, Yunnan Xinli, Anshan Hailiang, Baotai Huashen

Scope of The Market Report:

The report offers a forward-looking perspective on different factors driving or limiting the market growth. An exceptionally workable estimation of the present industry scenario has been delivered in the study, and the global Titanium Sponge market size with regards to the revenue and volume have also been mentioned. In short, the report provides a detailed analysis of the global market size, regional and country-level market size, segment growth, market share, competitive landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, and recent developments in different regions.

The report offers an in-depth assessment of the growth and other aspects of the market in key countries including the

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Global Titanium Sponge market by Type: Ti>99.7, Ti 99.5~99.7, Ti 99.3~99.5, Ti below 99.3

Global Titanium Sponge market by application: Aerospace & Defense, Chemicals, Ocean & Ship, Electric Power, Other

READ FULL REPORT: https://www.mrinsights.biz/report/global-titanium-sponge-market-growth-2020-2025-236091.html

The Listing Supplies Hints On The Upcoming Pointers:

Business Diversification: Market information about new services, untapped geographies, the latest advances, and also investments.

Assessment: In-depth investigation of plans, services, and manufacturing capabilities of these top players.

Business Intelligence: Comprehensive information on Titanium Sponge made accessible the very active players in the global sector.

Product Development/Innovation: Comprehensive information about technology, R&D pursuits, together with brand new product launches out of the global Titanium Sponge market.

Market Development: Comprehensive information regarding flourishing emerging markets in which the report assesses the market to get worldwide records

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs.

View post:
COVID-19 IMPACT ON Titanium Sponge Market | VOLUME, ANALYSIS, FUTURE PREDICTION, INDUSTRY OVERVIEW AND FORECAST 2025 - Cole of Duty

Read More...

Animal Stem Cell Therapy Market 2020 Analysis of Competitive Developments Such As Expansions, Agreements, New Product Launches, And Acquisitions In…

May 27th, 2020 12:06 pm

Latest Report On Animal Stem Cell Therapy Market including Market Landscape, and Market size, Revenues by players, Revenues by regions, Average prices, Competitive landscape, market Dynamics and industry trends and developments during the forecast period.

The global Animal Stem Cell Therapy market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Animal Stem Cell Therapy market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global market. The authors of the report profile leading companies of the global Animal Stem Cell Therapy market, Also the details about important activities of leading players in the competitive landscape.

Key companies operating in the global Animal Stem Cell Therapy market include: , Medivet Biologics LLC, VETSTEM BIOPHARMA, J-ARM, U.S. Stem Cell, Inc, VetCell Therapeutics, Celavet Inc., Magellan Stem Cells, Kintaro Cells Power, Animal Stem Care, Animal Cell Therapies, Cell Therapy Sciences, Animacel

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1427718/global-animal-stem-cell-therapy-market

The report predicts the size of the global Animal Stem Cell Therapy market in terms of value and volume for the forecast period 2020-2026. As per the analysis provided in the report, the global Animal Stem Cell Therapy market is expected to rise at a CAGR of xx % between 2020 and 2026 to reach a valuation of US$ xx million/billion by the end of 2026. In 2020, the global Animal Stem Cell Therapy market attained a valuation of US$ XX million/billion. The market researchers deeply analyze the global Animal Stem Cell Therapy industry landscape and the future prospects it is anticipated to create

Segmental Analysis

The report has classified the global Animal Stem Cell Therapy industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Animal Stem Cell Therapy manufacturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Animal Stem Cell Therapy industry.

Global Animal Stem Cell Therapy Market Segment By Type:

, :, Dogs, Horses, Others ,

Global Animal Stem Cell Therapy Market Segment By Application:

: Veterinary Hospitals Research Organizations

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global Animal Stem Cell Therapy industry. In order to fulfill the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Animal Stem Cell Therapy market include: , Medivet Biologics LLC, VETSTEM BIOPHARMA, J-ARM, U.S. Stem Cell, Inc, VetCell Therapeutics, Celavet Inc., Magellan Stem Cells, Kintaro Cells Power, Animal Stem Care, Animal Cell Therapies, Cell Therapy Sciences, Animacel

Key questions answered in the report:

Enquire for Customization in the Report: https://www.qyresearch.com/customize-request/form/1427718/global-animal-stem-cell-therapy-market

TOC

Table of Contents 1 Animal Stem Cell Therapy Market Overview1.1 Product Overview and Scope of Animal Stem Cell Therapy1.2 Animal Stem Cell Therapy Segment by Type1.2.1 Global Animal Stem Cell Therapy Sales Growth Rate Comparison by Type (2021-2026)1.2.2 Dogs1.2.3 Horses1.2.4 Others1.3 Animal Stem Cell Therapy Segment by Application1.3.1 Animal Stem Cell Therapy Sales Comparison by Application: 2020 VS 20261.3.2 Veterinary Hospitals1.3.3 Research Organizations1.4 Global Animal Stem Cell Therapy Market Size Estimates and Forecasts1.4.1 Global Animal Stem Cell Therapy Revenue 2015-20261.4.2 Global Animal Stem Cell Therapy Sales 2015-20261.4.3 Animal Stem Cell Therapy Market Size by Region: 2020 Versus 2026 2 Global Animal Stem Cell Therapy Market Competition by Manufacturers2.1 Global Animal Stem Cell Therapy Sales Market Share by Manufacturers (2015-2020)2.2 Global Animal Stem Cell Therapy Revenue Share by Manufacturers (2015-2020)2.3 Global Animal Stem Cell Therapy Average Price by Manufacturers (2015-2020)2.4 Manufacturers Animal Stem Cell Therapy Manufacturing Sites, Area Served, Product Type2.5 Animal Stem Cell Therapy Market Competitive Situation and Trends2.5.1 Animal Stem Cell Therapy Market Concentration Rate2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)2.6 Manufacturers Mergers & Acquisitions, Expansion Plans2.7 Primary Interviews with Key Animal Stem Cell Therapy Players (Opinion Leaders) 3 Animal Stem Cell Therapy Retrospective Market Scenario by Region3.1 Global Animal Stem Cell Therapy Retrospective Market Scenario in Sales by Region: 2015-20203.2 Global Animal Stem Cell Therapy Retrospective Market Scenario in Revenue by Region: 2015-20203.3 North America Animal Stem Cell Therapy Market Facts & Figures by Country3.3.1 North America Animal Stem Cell Therapy Sales by Country3.3.2 North America Animal Stem Cell Therapy Sales by Country3.3.3 U.S.3.3.4 Canada3.4 Europe Animal Stem Cell Therapy Market Facts & Figures by Country3.4.1 Europe Animal Stem Cell Therapy Sales by Country3.4.2 Europe Animal Stem Cell Therapy Sales by Country3.4.3 Germany3.4.4 France3.4.5 U.K.3.4.6 Italy3.4.7 Russia3.5 Asia Pacific Animal Stem Cell Therapy Market Facts & Figures by Region3.5.1 Asia Pacific Animal Stem Cell Therapy Sales by Region3.5.2 Asia Pacific Animal Stem Cell Therapy Sales by Region3.5.3 China3.5.4 Japan3.5.5 South Korea3.5.6 India3.5.7 Australia3.5.8 Taiwan3.5.9 Indonesia3.5.10 Thailand3.5.11 Malaysia3.5.12 Philippines3.5.13 Vietnam3.6 Latin America Animal Stem Cell Therapy Market Facts & Figures by Country3.6.1 Latin America Animal Stem Cell Therapy Sales by Country3.6.2 Latin America Animal Stem Cell Therapy Sales by Country3.6.3 Mexico3.6.3 Brazil3.6.3 Argentina3.7 Middle East and Africa Animal Stem Cell Therapy Market Facts & Figures by Country3.7.1 Middle East and Africa Animal Stem Cell Therapy Sales by Country3.7.2 Middle East and Africa Animal Stem Cell Therapy Sales by Country3.7.3 Turkey3.7.4 Saudi Arabia3.7.5 U.A.E 4 Global Animal Stem Cell Therapy Historic Market Analysis by Type4.1 Global Animal Stem Cell Therapy Sales Market Share by Type (2015-2020)4.2 Global Animal Stem Cell Therapy Revenue Market Share by Type (2015-2020)4.3 Global Animal Stem Cell Therapy Price Market Share by Type (2015-2020)4.4 Global Animal Stem Cell Therapy Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Animal Stem Cell Therapy Historic Market Analysis by Application5.1 Global Animal Stem Cell Therapy Sales Market Share by Application (2015-2020)5.2 Global Animal Stem Cell Therapy Revenue Market Share by Application (2015-2020)5.3 Global Animal Stem Cell Therapy Price by Application (2015-2020) 6 Company Profiles and Key Figures in Animal Stem Cell Therapy Business6.1 Medivet Biologics LLC6.1.1 Corporation Information6.1.2 Medivet Biologics LLC Description, Business Overview and Total Revenue6.1.3 Medivet Biologics LLC Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.1.4 Medivet Biologics LLC Products Offered6.1.5 Medivet Biologics LLC Recent Development6.2 VETSTEM BIOPHARMA6.2.1 VETSTEM BIOPHARMA Animal Stem Cell Therapy Production Sites and Area Served6.2.2 VETSTEM BIOPHARMA Description, Business Overview and Total Revenue6.2.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.2.4 VETSTEM BIOPHARMA Products Offered6.2.5 VETSTEM BIOPHARMA Recent Development6.3 J-ARM6.3.1 J-ARM Animal Stem Cell Therapy Production Sites and Area Served6.3.2 J-ARM Description, Business Overview and Total Revenue6.3.3 J-ARM Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.3.4 J-ARM Products Offered6.3.5 J-ARM Recent Development6.4 U.S. Stem Cell, Inc6.4.1 U.S. Stem Cell, Inc Animal Stem Cell Therapy Production Sites and Area Served6.4.2 U.S. Stem Cell, Inc Description, Business Overview and Total Revenue6.4.3 U.S. Stem Cell, Inc Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.4.4 U.S. Stem Cell, Inc Products Offered6.4.5 U.S. Stem Cell, Inc Recent Development6.5 VetCell Therapeutics6.5.1 VetCell Therapeutics Animal Stem Cell Therapy Production Sites and Area Served6.5.2 VetCell Therapeutics Description, Business Overview and Total Revenue6.5.3 VetCell Therapeutics Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.5.4 VetCell Therapeutics Products Offered6.5.5 VetCell Therapeutics Recent Development6.6 Celavet Inc.6.6.1 Celavet Inc. Animal Stem Cell Therapy Production Sites and Area Served6.6.2 Celavet Inc. Description, Business Overview and Total Revenue6.6.3 Celavet Inc. Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.6.4 Celavet Inc. Products Offered6.6.5 Celavet Inc. Recent Development6.7 Magellan Stem Cells6.6.1 Magellan Stem Cells Animal Stem Cell Therapy Production Sites and Area Served6.6.2 Magellan Stem Cells Description, Business Overview and Total Revenue6.6.3 Magellan Stem Cells Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.4.4 Magellan Stem Cells Products Offered6.7.5 Magellan Stem Cells Recent Development6.8 Kintaro Cells Power6.8.1 Kintaro Cells Power Animal Stem Cell Therapy Production Sites and Area Served6.8.2 Kintaro Cells Power Description, Business Overview and Total Revenue6.8.3 Kintaro Cells Power Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.8.4 Kintaro Cells Power Products Offered6.8.5 Kintaro Cells Power Recent Development6.9 Animal Stem Care6.9.1 Animal Stem Care Animal Stem Cell Therapy Production Sites and Area Served6.9.2 Animal Stem Care Description, Business Overview and Total Revenue6.9.3 Animal Stem Care Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.9.4 Animal Stem Care Products Offered6.9.5 Animal Stem Care Recent Development6.10 Animal Cell Therapies6.10.1 Animal Cell Therapies Animal Stem Cell Therapy Production Sites and Area Served6.10.2 Animal Cell Therapies Description, Business Overview and Total Revenue6.10.3 Animal Cell Therapies Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.10.4 Animal Cell Therapies Products Offered6.10.5 Animal Cell Therapies Recent Development6.11 Cell Therapy Sciences6.11.1 Cell Therapy Sciences Animal Stem Cell Therapy Production Sites and Area Served6.11.2 Cell Therapy Sciences Animal Stem Cell Therapy Description, Business Overview and Total Revenue6.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.11.4 Cell Therapy Sciences Products Offered6.11.5 Cell Therapy Sciences Recent Development6.12 Animacel6.12.1 Animacel Animal Stem Cell Therapy Production Sites and Area Served6.12.2 Animacel Animal Stem Cell Therapy Description, Business Overview and Total Revenue6.12.3 Animacel Animal Stem Cell Therapy Sales, Revenue and Gross Margin (2015-2020)6.12.4 Animacel Products Offered6.12.5 Animacel Recent Development 7 Animal Stem Cell Therapy Manufacturing Cost Analysis7.1 Animal Stem Cell Therapy Key Raw Materials Analysis7.1.1 Key Raw Materials7.1.2 Key Raw Materials Price Trend7.1.3 Key Suppliers of Raw Materials7.2 Proportion of Manufacturing Cost Structure7.3 Manufacturing Process Analysis of Animal Stem Cell Therapy7.4 Animal Stem Cell Therapy Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers8.1 Marketing Channel8.2 Animal Stem Cell Therapy Distributors List8.3 Animal Stem Cell Therapy Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porters Five Forces Analysis 10 Global Market Forecast10.1 Global Animal Stem Cell Therapy Market Estimates and Projections by Type10.1.1 Global Forecasted Sales of Animal Stem Cell Therapy by Type (2021-2026)10.1.2 Global Forecasted Revenue of Animal Stem Cell Therapy by Type (2021-2026)10.2 Animal Stem Cell Therapy Market Estimates and Projections by Application10.2.1 Global Forecasted Sales of Animal Stem Cell Therapy by Application (2021-2026)10.2.2 Global Forecasted Revenue of Animal Stem Cell Therapy by Application (2021-2026)10.3 Animal Stem Cell Therapy Market Estimates and Projections by Region10.3.1 Global Forecasted Sales of Animal Stem Cell Therapy by Region (2021-2026)10.3.2 Global Forecasted Revenue of Animal Stem Cell Therapy by Region (2021-2026)10.4 North America Animal Stem Cell Therapy Estimates and Projections (2021-2026)10.5 Europe Animal Stem Cell Therapy Estimates and Projections (2021-2026)10.6 Asia Pacific Animal Stem Cell Therapy Estimates and Projections (2021-2026)10.7 Latin America Animal Stem Cell Therapy Estimates and Projections (2021-2026)10.8 Middle East and Africa Animal Stem Cell Therapy Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

About Us

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from a huge number of customer supports, the QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.

Read more from the original source:
Animal Stem Cell Therapy Market 2020 Analysis of Competitive Developments Such As Expansions, Agreements, New Product Launches, And Acquisitions In...

Read More...

Nickel Iodide Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026 – Cole of Duty

May 27th, 2020 12:06 pm

Global Nickel Iodide Market comprehensive analysis of the business models, key ways, and individual market shares of a number of the foremost outstanding players during this landscape. AN in-depth statement on the key influencing factors, market statistics in terms of revenues, segment-wise knowledge, region-wise knowledge, and country-wise knowledge are offered within the complete study. with growth trends, numerous stakeholders like investors, CEOs, traders, suppliers, analysis & media, international Manager, Director, President, SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization et al. . This report focuses on Professional Global Nickel Iodide Market 2020-2025 volume and value at Global level, regional level and company level.

Ask For Sample of Global Nickel Iodide Market 2020: http://www.researchreportsinc.com/report-sample/581253

Global Nickel Iodide Market 2020 report provides key statistics on the market status of the Nickel Iodide Manufacturers and should be a valuable source of guidance and direction for companies and individuals curious about the Nickel Iodide Industry. The Nickel Iodide industry report firstly announced the Nickel Iodide Market fundamentals: type applications and market overview, product specifications, manufacturing processes, cost structures, raw materials then on.

Company 1, Company 2, Company 3, Company 4, Company 5, Company 6, Company 7, Company 8, Company 9, Company 10, Company 11, Company 12, Company 13, Company 14, Company 15

Ask For Customized Report as per Your Business Requirement: http://www.researchreportsinc.com/send-an-enquiry/581253

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Columbia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Buy This Report: http://www.researchreportsinc.com/checkout/581253

The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information,growth rate of Nickel Iodide market in 2025is also explained. Additionally, type wise and application wise consumption tables and figures of Nickel Iodide market are also given.

About Research Reports Inc:

Research Reports Inc. is one of the leading destinations for market research reports across all industries, companies, and technologies. Our repository features an exhaustive list of market research reports from thousands of publishers worldwide. We take pride in curating a database covering virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. We are one of the premier sources for such reports & report customization services.

Contact Us:

David ( Sales Manager )

US: +1-855-419-2424

UK : +440330807757

Email: [emailprotected]

Read more from the original source:
Nickel Iodide Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026 - Cole of Duty

Read More...

Construction Glass Market Future Scope, Top Key Players and Forecast By… – Azizsalon News

May 27th, 2020 12:06 pm

A recent report published by QMI on construction glass market is a detailed assessment of the most important market dynamics. After carrying out thorough research on the market of construction glass historical as well as current growth parameters, business expectations for growth are obtained with utmost precision. The study identifies specific and important factors affecting the market for construction glass during the forecast period. It can enable manufacturers of construction glass to change their production and marketing strategies in order to envisage maximum growth. The market report on construction glass offers detailed information for stakeholders in the most comprehensive way on the current and future growth prospects of the demand for construction glass market.

To Request Sample Premium Reports: https://www.quincemarketinsights.com/request-sample-60644?utm_source=SSK&utm_medium=AS&utm_campaign=SSK

This report provides comprehensive taxonomy and the description of industry-related products, applications and end-user channels for the construction glass market. This report also provides insight into market concepts for phase. This contains opportunity analysis which provides information on the most relevant macroeconomic and microeconomic factors affecting market revenues and estimates for the phase. The market background is discussed in the report which sheds a light on the key drivers, threats, patterns and opportunities in the demand for construction glass market. A global overview has been presented for case packers products, supply chain analysis and hazard analysis, which is expected to help readers identify the key factors that support the growth of the demand for construction glass market. The report discusses the regulatory scenario affecting approvals for the products, across leading regions. It also provides information on the demand of the construction glass market adopted in leading countries. It includes a specific list of retailers and manufacturers dealing in construction glass market. Readers will also be able to find regional developments and regulations that impact market growth. Significant growth prospects are given for countries which also include key regional developments and factors that influence the growth of the demand for construction glass market. The report studies business patterns of top companys like- fujifilm holdings corporation, analogic corporation, siemens healthcare, esaote s.p.a, toshiba medical systems corporation, get healthcare, philips healthcare, hitachi medical corporation, and mindray medical international ltd

Get TOC For The Overview Of The Premium Report: https://www.quincemarketinsights.com/request-toc-60644?utm_source=SSK&utm_medium=AS&utm_campaign=SSK

Construction glass market growth is expected to gain high momentum during the forecast period due to increasing demand for imaging devices for diagnostics applications. An ceiling-mounted surgical lights is a medical imaging device, which uses high-frequency waves to visualize the internal organs of the body such as blood vessels, kidney, liver, human foetus, heart, etc. This market is gaining momentum, owing to the increase in the number of hospitals and adoption of technologically advanced devices, which can serve the purpose for both diagnostics and therapeutics. Moreover, the cumulative prevalence of cancer is driving the demand for early detections and minimization of expenses. According to the Cancer Research Institute (CRI), there were approximately 17 million new cases of cancer globally, as of 2017, which is also fuelling the demand for ultrasound devices.

Segment Analysis

The bed head multifunctional belt market has been segmented into product type, device display, portability, and application. Based on product type, the market has been divided into diagnostic and therapeutic. The diagnostic product type segment can be further divided into 2D ultrasound, 3D/4D ultrasound, and Doppler ultrasound. The therapeutic segment can be further divided into shockwave lithotripsy and focused ultrasound. The growth of the bed head multifunctional belt market can be attributed to its advanced technology and increased efficacy.

Based on the device display, the market can be segmented into colour ultrasound and black/white ultrasound. Based on portability, the market can be divided into trolley/cart and compact/handheld. Based on application, the market has been divided into radiology, gynaecology, urology, cardiology, orthopaedic/musculoskeletal, and others. Owing to the growing incidences of stem cell-based injuries and the demand for high-quality diagnostic procedures, the radiology segment is expected to lead. The market has been studied for North America, Western Europe, Eastern Europe, Asia Pacific, and Rest of the World.

Key Factors Impacting Market Growth:

Regional Outlook:

North America, Western Europe, and Asia Pacific by region are estimated to dominate the ultrasound market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favourable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for ultrasound market during the forecast period.The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for ultrasound market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for ultrasound market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for ultrasound during the forecast period.

Speak To Analyst before Buying This: https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-60644?utm_source=SSK&utm_medium=AS&utm_campaign=SSK

Companies Covered: Beck Technology, Ltd., Autodesk, Inc., Dassault Systemes SA, Trimble Navigation Ltd, Synchro Software Ltd, Pentagon Solutions Ltd, Bentley Systems.

Market Segmentation:By Type: Low-E Glass Special GlassBy Manufacturing Process : Float Process Rolled/Sheet ProcessBy Chemical Composition: Potash-Lime Glass Potash-Lead Glass Soda-Lime GlassBy Application: Residential Commercial Others

By Region: North America North America, by Country US Canada Mexico North America, by Type North America, by Manufacturing Process North America, by Chemical Composition North America, by Application Western Europe Western Europe, by Country Germany UK France Italy Spain The Netherlands Rest of Western Europe Western Europe, by Type Western Europe, by Manufacturing Process Western Europe, by Chemical Composition Western Europe, by Application Asia Pacific Asia Pacific, by Country China India Japan South Korea Australia Indonesia Rest of Asia Pacific Asia Pacific, by Type Asia Pacific, by Manufacturing Process Asia Pacific, by Chemical Composition Asia Pacific, by Application Eastern Europe Eastern Europe, by Country Russia Turkey Rest of Eastern Europe Eastern Europe, by Type Eastern Europe, by Manufacturing Process Eastern Europe, by Chemical Composition Eastern Europe, by Application Middle East Middle East, by Country UAE Saudi Arabia Qatar Iran Rest of Middle East Middle East, by Type Middle East, by Manufacturing Process Middle East, by Chemical Composition Middle East, by Application Rest of the World Rest of the World, by Country South America Africa Rest of the World, by Type Rest of the World, by Manufacturing Process Rest of the World, by Chemical Composition Rest of the World, by Application

Reasons to Buy This Report:

Customization:

We provide customization of the study to meet specific requirements:

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact:

Quince Market Insights

Ajay D. (Knowledge Partner)

Office No- A109

Pune, Maharashtra 411028

Phone: US +1 208 405 2835 / UK +44 121 364 6144 / APAC +91 706 672 4848

Email: sales@quincemarketinsights.com

Web: http://www.quincemarketinsights.com

Read the original post:
Construction Glass Market Future Scope, Top Key Players and Forecast By... - Azizsalon News

Read More...

Pallet and Pallet Pooling Market 2020 With COVID-19 Impact Analysis, Business Opportunities and Future Outlook 2026 – Cole of Duty

May 27th, 2020 12:06 pm

The Pallet and Pallet Pooling Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

Get Free Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/05242040187/global-pallet-and-pallet-pooling-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread/inquiry?source=newscollective&Mode=07

Top LeadingCompaniesof Global Pallet and Pallet Pooling Market areEuro Pool System International, Contraload NV Demes, CABKA Group, Craemer Holding, Faber Halbertsma Group, Falkenhahn, Rehrig Pacific, HTR Paletten-Service, Buckhorn, LOSCAM, Brambles, Schoeller Allibert, Logistics GmbH and Co. KG, The Corrugated Pallets, PPS Midlands Limited, Greystone Logistics, ORBIS, iGPS Logistics LLCand others.

Global Pallet and Pallet Pooling Market Split by Product Type and Applications:

This report segments the global Pallet and Pallet Pooling market based onTypesare:PalletPallet Pooling

Based onApplication, the Global Pallet and Pallet Pooling market is segmented into:FMCGFood and BeveragePharmaceuticalsElectronicsChemical and PetrochemicalOthers

Global Pallet and Pallet Pooling Market: Regional Analysis

The report offers an in-depth assessment of the growth and other aspects of the Pallet and Pallet Pooling market in important regions, including the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, and Latin America.

Get 20% Exclusive Discount on this Report:

https://www.marketinsightsreports.com/reports/05242040187/global-pallet-and-pallet-pooling-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread/discount?source=newscollective&Mode=07

Important Sections from the Table of Contents:

The research includes historic data from 2015 to 2020 and forecasts until 2026 which makes the report an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Finally, the Pallet and Pallet Pooling Market report is a believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. Pallet and Pallet Pooling industry report additionally Present a new task SWOT examination, speculation attainability investigation, and venture return investigation.

Browse Full Report at:

https://www.marketinsightsreports.com/reports/05242040187/global-pallet-and-pallet-pooling-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread?source=newscollective&Mode=07

We Offer Customization On Report Based On Specific Client Requirement: Free country Level analysis for any 5 countries of your choice. Free Competitive analysis of any 5 key market players. Free 40 analyst hours to cover any other data point.

About Us:

MarketInsightsReportsprovides syndicated market research on industry verticals includingHealthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.MarketInsightsReportsprovides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

[emailprotected]|[emailprotected]

Go here to read the rest:
Pallet and Pallet Pooling Market 2020 With COVID-19 Impact Analysis, Business Opportunities and Future Outlook 2026 - Cole of Duty

Read More...

Blood and Organ Bank Market Key Trends, Drivers, Challenges and Standardization To 2020-2026 – Cole of Duty

May 27th, 2020 12:06 pm

The Blood and Organ Bank market report [6 Years Forecast 2020-2026] focuses on the COVID19 Outbreak Impact analysis of key points influencing the growth of the market. Providing info like market competitive situation, product scope, market overview, opportunities, driving force and market risks. Profile the Top Key Players of Blood and Organ Bank, with sales, revenue and global market share of Blood and Organ Bank are analyzed emphatically by landscape contrast and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is additionally administrated. The Blood and Organ Bank market business development trends and selling channels square measure analyzed. From a global perspective, It also represents overall industry size by analyzing qualitative insights and historical data.

The study encompasses profiles of major companies operating in the global Blood and Organ Bank market. Key players profiled in the report includes : American Red Cross, New England Donor Services, 21st Century Medicine, New York Blood Centre, The Living Bank, Musculoskeletal Transplant Foundation, National Organ & Tissue Transplant Organisation, China Cord Blood Corporation, National Cord Blood Program, Cord Blood Registry, and among others.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Blood and Organ Bank Market @https://www.researchmoz.us/enquiry.php?type=S&repid2374425

The Blood and Organ Bank market report provides a comprehensive analysis of:Industry overview, cost structure analysis, technical data and competitive analysis, topmost players analysis, development trend analysis, overall market overview, regional market analysis, consumers analysis and marketing type analysis.

Scope of Blood and Organ Bank Market:

The global Blood and Organ Bank market is valued at million US$ in 2019 and will reach million US$ by the end of 2026, growing at a CAGR of during 2020-2026. The objectives of this study are to define, segment, and project the size of the Blood and Organ Bank market based on company, product type, application and key regions.

This report studies the global market size of Blood and Organ Bank in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Blood and Organ Bank in these regions.

This research report categorizes the global Blood and Organ Bank market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors, customers, research findings & conclusion, appendix & data source and Porters Five Forces Analysis.

The end users/applications and product categories analysis:

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate foreach application.

On the basis of product,this report displays the sales volume, revenue (Million USD), product price, market share and growth rate ofeach type.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid2374425

(*Fill the form and our sales representative will get back to you for assistance)

Blood and Organ Bank Market The Regional analysis covers:

Key Takeaways and Reasons To Buy Blood and Organ Bank Market Report:

And Many More.Contact Us:

ResearchMozMr. Rohit Bhisey,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email: [emailprotected]Follow us on LinkedIn @ http://bit.ly/2RtaFUo

Follow me on : https://marketnews-24.blogspot.com/

Read more from the original source:
Blood and Organ Bank Market Key Trends, Drivers, Challenges and Standardization To 2020-2026 - Cole of Duty

Read More...

Hair regeneration using stem cells to treat baldness – BioNews

May 27th, 2020 12:04 pm

26 May 2020

Stem cells derived from fat can lead to hair regrowth for people with a common type of baldness, according to a new study.

The South Korean researchersconducted a clinical trial into androgenetic alopecia (AGA), the most common cause of hair loss. The trial showed that the use of extracts of fat tissue termed adipose-derived stem cell constituent extract (ADSC-CE) increasedboth hair thickness and density in patients.

'Recent studies have shown that ADSCs promote hair growth in both men and women with alopecia. However, no randomised, placebo-controlled trial in humans has explored the effects and safety of ADSC-CE in AGA. We aimed to assess the efficacy and tolerability of ADSC-CE in middle-aged patients with AGA in our study, hypothesising that it is an effective and safe treatment agent,' said corresponding author Dr Sang Lee from Pusan National University Yangsan Hospital.

To make their solution, the team disrupted the membrane of stem cells found in fat tissues using a low-frequency ultrasound wave and enriched the secreted stem cell with protein. They recruited 38 patients 29 men and nine women with AGA for the clinical trial. One half applied the ADSC-CE lotion to their scalp with their fingers, and the other applied a placebo solution.

A dot was tattooed on the participants'scalps in order to compare the same spot over time. After 16 weeks, the group that used the ADSC-CE lotion presented a significant increase in hair density with 28.1 percent in comparison to 7.1 percent in the control group, and also hair thickness with 14.2 percent in comparison to 6.3 percent in the control group.

The results from this clinical trial, published in the journal Stem Cells Translational Medicine, presented no side-effects, and provide an alternative to current hair therapeutic strategies that have been associated with loss of libido and erectile disfunction.

Further research is required to understand the molecular mechanisms by which ADSC-CE can affect hair growth in humans. 'The next step should be to conduct similar studies with large and diverse populations in order to confirm the beneficial effects of ADSC-CE on hair growth and elucidate the mechanisms responsible for the action of ADSC-CE in humans,' said Dr Lee.

See the original post:
Hair regeneration using stem cells to treat baldness - BioNews

Read More...

AgeX Therapeutics, Inc. Appoints Andrea Park as Chief Financial Officer – Yahoo Finance

May 27th, 2020 12:04 pm

AgeX Therapeutics , Inc. ("AgeX": NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that Andrea Park has been appointed Chief Financial Officer. Ms. Park replaces Russell Skibsted who served in that role since the Company was organized in 2017.

Andrea Park served as our Vice President of Finance and Controller since October 2019. Her career includes over 24 years of public accounting and finance experience. Before joining AgeX, she served as Vice President of Finance and Controller of Lineage Cell Therapeutics, Inc. While at Lineage from August 2009 to September 2019, Ms. Park was directly involved in the accounting and financial reporting of the public spin-off and eventually the deconsolidation of three of its then subsidiaries including Asterias Biotherapeutics, Inc., OncoCyte Corporation and AgeX. Earlier in her career she has worked in the audit and assurance practice at Deloitte. Ms. Park has a B.A. in Business Economics with Concentration in Accounting from the University of California, Santa Barbara.

Mr. Skibsted will continue to provide services to the company as a consultant.

About AgeX Therapeutics

AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics for human aging. Its PureStem and UniverCyte manufacturing and immunotolerance technologies are designed to work together to generate highly defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeXs revolutionary longevity platform induced Tissue Regeneration (iTR) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. AGEX-iTR1547 is an iTR-based formulation in preclinical development. HyStem is AgeXs delivery technology to stably engraft PureStem cell therapies in the body. AgeXs core product pipeline is intended to extend human healthspan. AgeX is seeking opportunities to establish licensing and collaboration arrangements around its broad IP estate and proprietary technology platforms and therapy product candidates.

For more information, please visit http://www.agexinc.com or connect with the company on Twitter, LinkedIn, Facebook, and YouTube.

Forward-Looking Statements

Certain statements contained in this release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not historical fact including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates" should also be considered forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of AgeX Therapeutics, Inc. and its subsidiaries, particularly those mentioned in the cautionary statements found in more detail in the "Risk Factors" section of AgeXs most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commissions (copies of which may be obtained at http://www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. AgeX specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200521005241/en/

Contacts

Michael D. West, Ph.D.mwest@agexinc.com (510) 671-8370

Read more:
AgeX Therapeutics, Inc. Appoints Andrea Park as Chief Financial Officer - Yahoo Finance

Read More...

Sales Revenue in the Stromal Vascular Fraction Market to Witness Growth at Robust CAGR 4.5% During 2019 to 2029 – Cole of Duty

May 27th, 2020 12:04 pm

New York City, United States The change during the COVID-19 pandemic has overhauled our dependence on pattern setting developments, for instance, expanded reality, computer generated reality, and the Healthcare web of things. The unfulfilled cash related targets are persuading the relationship to grasp robotization and forefront advancements to stay ahead in the market competition. Associations are utilizing this open entryway by recognizing step by step operational needs and showing robotization in it to make an automated structure as far as might be feasible.

Stromal vascular fraction is gaining significant importance in various fields, including internal medicine, orthopaedics, plastic and general surgery,and wound healing.

Ease of harvest, abundant availability, and stable phenotype are some factors increasing the demand for stromal vascular fraction. Also, stromal vascular fraction secretes several soluble factors with anti-inflammatory, immunomodulatory, and analgesic effects, which leads to an alternative treatment option for various diseases, significantly benefitting the growth of thestromal vascular fraction marketduring the forecast period.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/20914

Company Profiles

Delivery of stromal vascular fraction by intra-articular injection has advantages over surgical implantation, such as less invasiveness, better patient compliance, and lower cost.

The global stromal vascular fraction market was valued atUS$ 76 Mnin 2018, and is expected to witness a CAGR of around4%over the forecast period (2019-2029).

Key Takeaways of Stromal Vascular Fraction Market Study

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/20914

Stromal vascular fraction has emerged as an efficient alternative in the field of regenerative medication. However, better-structured and significant clinical investigations need to be carried out to demonstrate and define the therapeutic potential of stromal vascular fraction,says a PMR analyst.

Stromal Vascular Fraction Manufacturers Focusing on Innovative Methods to Optimize Tissue Recovery

Consistent up-gradation and innovation in methods to recover adipose tissue-derived mesenchymal stem cells (ATD-MSCs) for autologous use in regenerative medication applications are expected to offer significant opportunities for the stromal vascular fraction market.

For instance, LipoCell from Tissyou, is furnished with a semipermeable film that separates fat tissues from squander components with the assistance of continuous irrigation. The dialysis of the tissue limits the pressure and trauma to the cell and extracellular matrix, evacuating the blood and oil deposits, which are pro-inflammatory.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/20914

More Valuable Insights on Stromal vascular fraction Market

Persistence Market Research brings a comprehensive research report on the forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the segments from 2014 to 2029.

The global stromal vascular fraction market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provide compelling insights on the stromal vascular fraction market on basis of product (SVF isolation products, SVF aspirate purification products, and SVF transfer products), application (cosmetic applications, orthopedic applications, soft tissue applications, and others), and end user (hospitals, ambulatory surgical centers, stem cell laboratories, and others), across six major regions.

What the report encloses for the readers:

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Liquid Chromatographymass Spectroscopy MarketLiquid Chromatography-Mass Spectroscopy Segmented By Triple Quadrupole, Time of Flight, Quadrupole Technology in Clinical Testing, Environmental Testing, Forensic Testing.For More Information

Biopharmaceutical MarketBiopharmaceuticals Market Segmented By Monoclonal Antibodies, Recombinant Proteins, Granulocyte-Colony Stimulating Factor, Interferons, Recombinant Human Insulin, Erythropoietin, Vaccines, Growth Hormones, Purified Proteins Type for Metabolic Disorders, Oncology, Neurological Disorders, Cardiovascular Diseases, Inflammatory and Infectious Diseases.For More Information

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

View post:
Sales Revenue in the Stromal Vascular Fraction Market to Witness Growth at Robust CAGR 4.5% During 2019 to 2029 - Cole of Duty

Read More...

Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome – Yahoo Finance

May 27th, 2020 12:03 pm

Vulcan Capital-led investment will enable Nautilus to bring a next-generation, single-molecule proteomics platform to market

Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76 million in an oversubscribed Series B offering that closed on Monday, May 18, 2020. Nautilus total funding now exceeds $100 million. The Nautilus platform will deliver single-molecule sensitivity more quickly, more completely, and less expensively than is possible with existing technologies. This deeper, richer understanding of proteins will enable a dramatic acceleration of basic science research, significantly improve the success rate of therapeutic development, and speed the adoption of personalized and predictive medicine.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200521005020/en/

Nautilus Biotechnology founders Sujal Patel and Parag Mallick (Photo: Business Wire)

The funding round was led by Vulcan Capital, the multi-billion-dollar investment arm of Vulcan Inc., the company founded by Microsoft co-founder and philanthropist Paul G. Allen. In addition to Vulcan, Perceptive Advisors, Bezos Expeditions, and Defy Partners were new investors in the Series B offering. Previous investors AME Cloud Ventures, Andreessen Horowitz, Bolt, and Madrona Venture Group also participated in the round. The capital will be used to accelerate development of Nautilus proprietary proteomics platform and the expansion of scientific and engineering staff across a variety of levels and disciplines.

Nautilus was co-founded in 2016 by Sujal Patel, founder and CEO of Isilon Systems, a publicly-traded company that sold to EMC in 2010 for $2.6B, and Parag Mallick, PhD, Associate Professor of Radiology at Stanford University and a member of BioX, Stanford's pioneering interdisciplinary biosciences institute, and the Canary Center for Cancer Early Detection. The leadership team combines its entrepreneurial and research backgrounds to solve the challenge of more easily and completely quantifying the proteins that drive every aspect of human physiology. That limitation has impeded scientific and pharmaceutical R&D and Nautilus platform will enable a more comprehensive understanding of cellular and organismic biology.

"Existing proteomics technologies are slow, expensive, incomplete, and lack the sensitivity to deliver deep and meaningful insight into biological processes," said Nautilus co-founder and CEO, Sujal Patel. "Bringing together Parags breakthrough science with my deep understanding of large-scale IT has enabled us to approach the problem in a fundamentally new, more holistic way. Our value derives from a unique, interdisciplinary combination of biochemistry, computer science, and substantial business experience."

"The potential of proteomics has not been fully realized because of the limitations of current analysis methods," said Lee Hartwell, PhD, President and Director Emeritus of the Fred Hutchinson Cancer Research Center, 2001 co-recipient of the Nobel Prize in Physiology and Medicine, and member of Nautilus Scientific Advisory Board. "A greater resolution of the proteome will make it possible for the entire scientific and pharma R&D communities to undertake a wider range of high-value scientific inquiries, thereby accelerating both their research and the benefits that can accrue to human health."

Story continues

"Advancing scientific research and technology is at our core," said Stuart Nagae, Director of Venture Capital at Vulcan Capital. "With over a decade of experience investing in biotech and proteomics innovation, we believe that a reimagining of proteomics is long overdue. Nautilus has put together a special team with the vision, creativity, and experience to achieve that breakthrough, and execute on their vision."

ABOUT NAUTILUS BIOTECHNOLOGY

Based in San Carlos, CA and Seattle, WA, Nautilus is a biotechnology company whose proteomics platform will deliver superior sensitivity far more quickly, more completely, and less expensively than is currently possible. By breaking through the limitations of existing technologies, and effectively democratizing proteomics, Nautilus will enable a dramatic acceleration of basic science research, significantly improve the success rate of therapeutic development, and usher in a new era of personalized and predictive medicine. Find Nautilus online: http://www.nautilus.bio

ABOUT VULCAN CAPITAL

Vulcan Capital is the multi-billion-dollar investment arm of Vulcan Inc., the company founded by Microsoft co-founder and philanthropist Paul G. Allen. Vulcan Capital focuses on generating long-term value appreciation across a portfolio, which spans diverse industry sectors and investment asset classes, ranging from early-stage venture investments to public equity value investing, leveraged buyouts, acquisitions, special situations and fixed income. Vulcan Capital was formed in 2003 and is headquartered in Seattle with additional offices in Palo Alto and Singapore.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200521005020/en/

Contacts

Nautilus Biotechnologypress@nautilus.bio

Kerry WalkerWalker Communicationskerry@walkercomms.com

The rest is here:
Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome - Yahoo Finance

Read More...

Page 533«..1020..532533534535..540550..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick